The answer to the question. Brightening is a shelf word that covers at least nine separate conditions: melasma, post-inflammatory hyperpigmentation, sun spots, acanthosis nigricans, friction and fold pigmentation, the normal hormonal colour of the genitals, nipples and anus, infections such as erythrasma and fungus, build-up that looks like pigment, and darkening caused by drugs or products. The biology underneath is shared, since every patch is made of the same melanin through the same enzyme, so the ingredient science travels from the face to the body. What changes by site is the trigger that keeps the pigment coming, the depth of the pigment, the kind of skin it sits in and the amount of research behind it. The face has a large trial literature, the underarm has one small placebo-controlled trial, and the inner thigh, buttocks and intimate skin have almost no controlled trials at all.
The umbrella map by body site. On the face, the usual causes are acne marks, melasma and sun spots, with light as the main trigger. On the neck, the usual causes are acanthosis nigricans from high insulin, friction from collars and necklaces, perfume reacting with sun, and build-up in a crease. On the underarm, the usual causes are a constitutionally darker baseline in medium and darker skin, irritation from repeated hair removal and products, the shadow of dark hair under pale skin, and less often acanthosis nigricans or erythrasma. On the inner thighs, the usual causes are friction, shaving along the bikini line, acanthosis nigricans and fungal infection in the crease. On the bikini line and intimate area, the colour is mostly normal and hormonal, with real irritation marks along the line where hair comes off. On the buttocks, the usual cause is the marks of folliculitis, plus sitting friction. On the knees and elbows, the usual causes are friction, leaning, kneeling and thick dry skin. On the nipples, the colour is normal and hormonal and deepens in pregnancy. On the hands, the usual cause is sun spots, and darker knuckles in darker skin are usually normal.
The general valley and aha. The valley is judging a product at three to six weeks, escalating to something stronger, getting irritated and darker, and watching any gain drift back after stopping, all held together by the belief that the colour is a stain and a stronger remover works faster. The aha is that the colour is the slow output of a process still being pushed, so the order is to stop the push, slow the pigment gently, and keep going for about three months with a maintenance step after that.
Valley and aha per site. For melasma, she clears it and it returns every summer, and the aha is that melasma behaves like a chronic condition driven partly by visible light, so a tinted iron-oxide sunscreen every day and gentle maintenance beat periodic aggression. For acne marks, she fades marks while new pimples arrive, and the aha is that the best brightener for acne marks is whatever stops the acne, while red marks are blood vessels that no brightener touches. For sun spots, she buys creams for years, and the aha is that one procedure removes a fixed spot. For the neck, she scrubs a patch that never moves, and the aha is that velvety thick skin is mostly insulin-driven thickening, so the test is touch and the treatment is lowering insulin. For the underarm, she escalates from lemon to acids to bleach, and the aha is that gentle beats strong on a thin shaved fold, the clock is nine to twelve weeks, and the deodorant is the one step she never skips. For the inner thighs, she treats a patch that is rubbed raw again every day, and the aha is that friction is the engine at every body size, so stopping the rub comes first, and an itchy patch with a spreading edge is an infection. For the bikini line, she treats normal hormonal colour and razor marks as one problem, and the aha is to separate them, treat the line where the hair comes off and leave the normal colour alone. For the buttocks, she fades spots while the bumps keep coming, and the aha is to treat the folliculitis. For the knees and elbows, she scrubs harder, and the aha is that rubbing makes pigment, so soften the skin with lactic acid or urea and stop scrubbing.
What it means for Doe. The deodorant format answers the clock and the drift, because a leave-on product on the exact patch every morning is the best adherence system the category has. It also raises the bar on gentleness, because any irritant in a deodorant lands on shaved skin every day. The open formula questions are the kojic and phenylethyl resorcinol percentages, whether mandelic acid is really in the stick, the fragrance level, furocoumarin-free bergamot and patch test data. The same logic reaches the inner thigh best, through a fragrance-free anti-chafe stick with actives, then the bikini line through a post-shave product, then knees and elbows through a lotion, and it does not reach the neck, the intimate area or the nipples.
Five numbers to memorise. First, seventeen point two percent of about forty-eight thousand adults in thirty-four countries reported darker underarms in the I’SPOT survey, the second most common pigment complaint after sun spots. Second, nine weeks, the measuring point of the only placebo-controlled underarm trial, in which four percent niacinamide gave a good-to-excellent result in twenty-four percent of twenty-four women against six percent on placebo. Third, eighty-two percent of women using four percent hydroquinone on the underarm in a trial of one hundred and fifty-three women had redness or irritation. Fourth, three and a half and forty-two, the multiples by which the underarm and the scrotum absorbed hydrocortisone compared with the forearm in Feldmann and Maibach’s 1967 study, which is why fold skin needs lower strengths. Fifth, eight hundred and six items in Doe’s customer-voice corpus name a second body area, and the question about inner thighs ranks in the top three objections on three of Doe’s five doors.
The buyers’ top phrases. Each line below is a buyer quote with its source.
The typed strings to remember are dark armpits and inner thighs, and dark armpits sign of diabetes.
Kalp, you asked whether brightening is one thing or an umbrella, and whether the underarm has its own literature or shares one with the face, the neck, the inner thighs and the bikini line. The short answer is that brightening is a shelf word that covers at least nine separate conditions, and each one has its own cause, its own clock and its own reason for coming back. The biology underneath all of them is shared, because every dark patch on every part of the body is made of the same pigment, produced by the same cells, through the same enzyme. What differs from site to site is the trigger that keeps the pigment coming, the depth at which the pigment sits, the kind of skin it sits in, and the amount of research anyone has bothered to do. This course takes those four differences apart, one body site at a time, so that you can stand in front of a woman who has tried everything for her underarms, her neck or her thighs and understand her problem better than she does.
The course runs in nine episodes. The first lays out the map. The second builds pigment from first principles, at the level of the cell. The third covers the face, where the money and the research are concentrated. The fourth covers the body, the folds and the places where friction, hormones and insulin do most of the work. The fifth sorts every brightening ingredient by how it works and explains why the same molecule behaves differently in a fold than on a cheek. The sixth asks how much of the evidence actually comes from each body site, with the size and length of every trial that exists for the underarm, thigh and intimate skin. The seventh covers the market: its size, its brands, its history in whitening and bleaching, and the rules that govern what you can say. The eighth listens to the buyers site by site. The ninth puts the valley and the aha on every site and asks what that means for Doe and for any product that might sit beside it.
The sibling deodorant course already built the dark underarm from the cell up in its seventh episode, and walked the Doe buyer through her journey in its eighth. This course assumes you have heard those, so the underarm appears here mainly as one site among many, and the time goes to what the deodorant course could not cover: the rest of the body, the face market that sets the buyer’s expectations, and the logic for deciding which neighbouring sites a deodorant format can and cannot reach.
The word brightening is a product of two pressures, one legal and one moral. The legal pressure comes from the American rule that a product which claims to change the structure or function of the body is a drug. A cream that says it lightens skin or bleaches dark spots makes a drug claim, and since the CARES Act of 2020 the only over-the-counter bleaching ingredient Americans could buy, hydroquinone, has been pulled from the non-prescription market. Brands that want to stay in the cosmetic lane therefore describe what the skin looks like, using words such as brighter, more even, radiant and glowing, and avoid words that describe what the product does to melanin.
The moral pressure comes from colourism. For most of the twentieth century the same products were sold across Asia and Africa as whitening and fairness creams, with advertising that tied lighter skin to marriage, jobs and love. In the summer of 2020, during the protests that followed the killing of George Floyd, Hindustan Unilever renamed Fair and Lovely as Glow and Lovely, Johnson and Johnson withdrew its Neutrogena Fine Fairness and Clean and Clear Fairness lines from Asia and the Middle East, and L’Oréal said it would remove the words white, fair and light from its skincare. The chemistry inside many of those jars did not change. The vocabulary did, and the vocabulary the whole industry moved to was brightening, even tone, glow and dark spots. Episode seven returns to this, because the words a buyer uses and the words a brand is allowed to use are part of the market.
So when a woman types brightening into a search bar, she might mean any of the following, and the products that answer her rarely ask which.
The first is melasma. Melasma is a patchy, symmetrical brown or grey-brown darkening of the face, usually on the cheeks, forehead, upper lip and jaw, seen far more often in women than in men, and triggered by a combination of hormones, ultraviolet light, visible light and heat. It has a vascular part and a deeper part, it is chronic, and it comes back, which makes it the hardest condition under the umbrella and the one with the largest research base.
The second is post-inflammatory hyperpigmentation, which dermatologists shorten to PIH. Any inflammation of the skin can leave extra pigment behind when it settles, whether the inflammation came from acne, a razor, a wax strip, eczema, an insect bite, a burn, friction or a peel that went too far. PIH is the single most common reason women of colour see a dermatologist about pigment, and most of the darkened folds on the body are a form of it.
The third is sun spots, which dermatologists call solar lentigines. These are flat, sharply edged brown spots on skin that has had years of sun, mostly on the face, the backs of the hands, the forearms and the upper chest, and they are the most common pigment complaint of all in lighter skin over forty.
The fourth is acanthosis nigricans, a velvety, thickened, dark skin in the folds of the neck, the armpits and the groin. It is a sign of insulin resistance in most people who have it, and it responds to weight loss and to treatment of the underlying metabolism far better than to any cream.
The fifth is friction and fold pigmentation. Skin that rubs against skin or fabric all day, such as the inner thighs, the groin, the buttock crease, the underarms, the knees and the elbows, slowly darkens and sometimes thickens. Some of this is PIH from chafing, some is the friction itself, and some overlaps with acanthosis nigricans.
The sixth is physiological pigment, the normal darker colour of the genitals, the nipples and areolae, and the skin around the anus. This colour is driven by hormones, deepens at puberty and in pregnancy, and is present in nearly everyone to some degree. It is a normal feature of the body and does not need treating, and a large part of the intimate lightening market sells against it anyway.
The seventh is infection that looks like pigment. Erythrasma, a bacterial infection of the folds, makes red-brown patches in the armpits and groin. Fungal infections such as tinea cruris in the groin and tinea versicolor on the trunk can leave darker or lighter patches. These need an antibiotic or an antifungal, and a brightener does nothing for them.
The eighth is build-up that looks like pigment. Dead skin, sweat, sebum and product residue can collect in a fold and form a dirty-looking film that soap does not remove. A condition called terra firma-forme dermatosis lifts off completely when wiped with rubbing alcohol, and a lot of what women on TikTok call dark underarms coming off on a cotton pad belongs here.
The ninth is drug and product darkening. Some medicines darken skin, including the antibiotic minocycline, the antimalarial hydroxychloroquine, the heart drug amiodarone and several chemotherapy drugs. Some products darken skin directly, including perfume containing bergamot oil on sun-exposed skin, a reaction called berloque dermatitis, and long-term use of high-strength hydroquinone, which can cause a permanent blue-black darkening called exogenous ochronosis. Mercury and strong steroid creams sold illegally as lighteners cause their own damage.
There is a tenth condition that is not pigment at all, and the market still sells brighteners against it. In a woman with pale skin and thick dark hair, the shaved underarm or bikini line can look grey because the hair shafts show through the skin. This is shadow from the hair, and it responds to waxing or laser hair removal, which take the hair out at the root.
Here is the map in prose, site by site, with the usual causes in rough order of how often they explain a woman’s complaint.
On the face, the main causes are acne PIH in younger women and in darker skin, melasma in women from their late twenties onward and especially in medium and darker skin, and sun spots in lighter skin from about forty. A darker ring around the eyes is its own complaint, partly pigment, partly blood vessels and partly the shadow of the skin’s shape.
On the neck, the main causes are acanthosis nigricans, which shows first at the back and sides, and friction from collars and necklaces. In lighter skin that has had decades of sun, a red-brown mottling on the sides of the neck, called poikiloderma of Civatte, spares the shaded skin under the chin. Perfume sprayed on the neck and then taken into the sun can leave a streak of berloque dermatitis.
On the underarms, the main causes are a constitutionally darker baseline in medium and darker skin, PIH from repeated hair removal and irritating products, the shadow of dark hair in pale skin, and acanthosis nigricans in a smaller group. The deodorant course covered these in depth.
On the inner thighs, the main causes are friction and chafing, PIH from shaving the bikini line, acanthosis nigricans in women with insulin resistance, and fungal infection in the warm, damp crease of the groin.
On the bikini line and the intimate area, the main causes are physiological hormone-driven pigment, which is normal, and PIH from shaving, waxing and ingrown hairs along the line where the hair is removed.
On the buttocks, the main causes are marks left by folliculitis and the acne-like bumps that come from sweat and tight clothing, friction from sitting, and the naturally darker skin of the crease.
On the knees and elbows, the main causes are friction from leaning and kneeling, thickened dry skin, and in some people acanthosis nigricans.
On the nipples and areolae, the colour is physiological and hormonal, and it darkens in pregnancy. On the hands, the main causes are sun spots on the backs of the hands with age, and in darker skin a darker colour over the knuckles that is usually normal.
The research money follows the face. Melasma and acne PIH have hundreds of clinical trials between them, many randomised and placebo-controlled, with standard scoring systems that let one trial be compared with another. The underarm has a handful of small trials, one of them placebo-controlled with twenty-four women. The inner thighs have almost no controlled trials at all; a search for randomised trials of inner thigh pigment returns blog posts and clinic pages. The vulva and perineum have a few small uncontrolled studies of peels, mostly from Brazil and from a Spanish manufacturer. Episode six goes through these one by one.
The market money is spreading from the face to the body. Face serums for dark spots are a mature category, with The Ordinary, Topicals, Good Molecules, Naturium, Paula’s Choice and the Korean brands competing on the same handful of ingredients. Body brightening is younger, fragmented and growing quickly, sold through TikTok, Amazon and Meta by brands such as Medicube, GloMelanin, Earthly Derm and Sugarbabycare, and by a ring of deodorants with actives in them, from Dove’s Even Tone line to Lume, Kosas, Nécessaire and Doe. A useful sign of where the body market is going came from Medicube, which in the autumn of 2026 ran separate creatives for underarms, elbows, knees and inner thighs, all pointing to one face serum repositioned for the body, according to the study of its Meta ads in our files.
The rest of the course turns on two ideas from the earlier courses, the valley and the aha. The valley is the place where most buyers get stuck, and in brightening it has the same shape on almost every site. A woman starts a product, sees nothing in the first three to six weeks because pigment moves slowly, concludes it is too weak, and reaches for something stronger. The stronger product irritates the skin, and irritated skin makes more pigment, so the patch stays the same or gets darker. If anything does work, the colour drifts back when she stops, and she concludes that nothing lasts. The aha that moves her out has three parts that hold everywhere: the colour is the slow output of a process that is still running, so the first job is to find and stop whatever is feeding it, whether that is light, friction, a razor, insulin or an irritating product; the clock is about three months because the skin needs several cycles of turnover to shed what is already there; and the care has to continue because the pigment cells keep their memory of the trigger. On each site the trigger is different, which is why the aha for the face is about light, the aha for the neck is about insulin, the aha for the thighs is about friction, and the aha for the underarm is about the daily injury of hair removal and the gentleness of the product that sits on that skin every morning.
The next episode builds the pigment system from the cell up, because every one of those trigger stories depends on it.
Every condition in this course runs on one machine, and once you can see the machine you can predict how each condition will behave, how fast it will move and why it comes back. The deodorant course gave the short version for the underarm. This episode goes one level deeper, because the differences between the face, the neck, the folds and the intimate skin are all differences in which part of the machine is being pushed, and how hard.
The outer layer of skin, the epidermis, is a stack of cells called keratinocytes that are born at the bottom, in a single layer called the basal layer, and rise toward the surface over several weeks, flattening and filling with the tough protein keratin until they die and are shed. Scattered along that basal layer, roughly one for every ten keratinocytes, sit the pigment cells, the melanocytes. A melanocyte looks like a small octopus. Its body sits on the basement membrane, the thin sheet that separates the epidermis from the deeper dermis, and it reaches long arms, called dendrites, up between the keratinocytes above it. One melanocyte supplies pigment to something like thirty to forty keratinocytes, and anatomists call that partnership the epidermal melanin unit.
The density of melanocytes varies across the body. Classic counts put it at roughly two thousand per square millimetre on the face and forearm and about one thousand on most of the trunk, and the genital skin is also at the high end. Across skin tones the counts are roughly the same, a fact that surprises most people. A woman with very dark skin and a woman with very pale skin have about the same number of pigment cells on the same patch of arm. The difference lies in how active those cells are, how large the pigment packets they make, how those packets are spread through the keratinocytes, and how quickly the keratinocytes break them down.
Melanin is made inside small sealed compartments in the melanocyte called melanosomes. Each melanosome matures through four stages, from an empty scaffold to a packet filled with pigment. The chemistry inside starts with the amino acid tyrosine, which the body gets from food and from another amino acid, phenylalanine. An enzyme called tyrosinase converts tyrosine into a molecule called DOPA and then into dopaquinone. Tyrosinase holds two copper atoms at its working site, which matters because several brightening ingredients work by grabbing that copper.
Dopaquinone is a fork in the road. If the sulphur-containing amino acid cysteine, or the antioxidant glutathione, is nearby in quantity, dopaquinone binds to it and the pathway makes pheomelanin, a red-yellow pigment. If cysteine is scarce, the pathway goes on through several more steps, two of them helped by enzymes called tyrosinase-related proteins one and two, and makes eumelanin, a brown-black pigment. Every person makes both pigments, and darker skin carries a larger share of eumelanin while red hair and freckled skin carry a larger share of pheomelanin. The switch between the two is set largely by a receptor on the melanocyte called MC1R, the melanocortin one receptor. When a hormone called alpha-melanocyte-stimulating hormone binds to MC1R, the cell makes more eumelanin; people with weak variants of the receptor make more pheomelanin, burn easily and tan poorly.
The fork explains one of the larger fads in the Asian lightening market. Glutathione pills, drips and injections are sold in the Philippines and across South and South-East Asia on the theory that flooding the body with glutathione will push the fork toward the lighter pheomelanin. The human evidence for any visible lightening from oral glutathione is thin and inconsistent, and the Philippine Food and Drug Administration has warned the public against injectable glutathione used for skin whitening. It comes up in buyer comments often enough that you should know where the idea comes from.
A finished melanosome is useless while it sits inside the melanocyte. It has to be handed up the dendrites to the keratinocytes. The keratinocytes take in the tips of the dendrites, packets and all, through a process that depends partly on a receptor on the keratinocyte called PAR-2. Once inside, the melanosomes gather over the top of the keratinocyte’s nucleus like a small parasol, shielding its DNA from ultraviolet light. As the keratinocyte rises and dies, it carries its parasol with it, and the pigment is shed with the dead cell at the surface.
In darker skin the melanosomes are large and spread out singly through the keratinocyte, and they are broken down slowly, so the pigment survives all the way up to the surface. In lighter skin they are smaller, bundled in groups, and broken down faster, so the upper layers carry less colour. This handing-up step is the second place a product can intervene. Niacinamide slows it, and soy extracts slow it by blocking the PAR-2 receptor.
The time a keratinocyte takes to travel from the basal layer to the surface and fall off is the clock that governs every brightening claim. In a young adult it is roughly four weeks, often quoted as twenty-eight days, and it slows with age to six or eight weeks by middle age. The length of this clock explains three separate things about brightening.
First, a product that slows pigment production cannot make the colour that is already in the upper layers disappear any faster than those layers are shed. The pigment made before the product started has to ride up and fall off on its own schedule, so even a perfect inhibitor needs at least one full turnover cycle before any change is visible, and usually two or three cycles before the change is large enough to see without a photograph.
Second, products that speed up shedding, such as glycolic, lactic and mandelic acid and the retinoids, can shorten the wait, but they do it by thinning and irritating the surface, and in darker skin irritation is a trigger for more pigment. Speeding the clock helps only up to the point where it starts to injure.
Third, the result does not hold by itself. The melanocyte is still there, with the same settings, and as soon as the inhibitor is removed or the trigger returns, it resumes making pigment at the old rate. Within one or two turnover cycles the colour drifts back toward where it started. Procter and Gamble’s work on niacinamide in the early two thousands documented exactly this reversal on facial spots, and it applies in principle to every ingredient that works by slowing production or transfer.
Melanocytes do not make pigment at a constant rate. They respond to signals, and every condition in this course corresponds to one or more of those signals being turned up.
Ultraviolet light is the best known. When ultraviolet light damages DNA in the keratinocytes, they release alpha-melanocyte-stimulating hormone and other messengers, which bind to MC1R on the melanocyte and switch on a master control gene called MITF, which in turn switches on tyrosinase. That chain is a tan, and it is why sunscreen is part of every serious treatment plan for facial pigment.
Visible light, the light we can see, also darkens skin, though only in medium and darker skin. A 2010 study by Mahmoud and colleagues, from the Henry Ford Hospital group in Detroit, showed that visible light produced immediate and lasting darkening in volunteers with skin types four to six and none in the lighter-skinned volunteers. Later work traced part of this to a light-sensing protein in the melanocyte called opsin three. This finding matters enormously for melasma, and it is why dermatologists now recommend tinted sunscreens containing iron oxide, which block visible light, over clear ones that block only ultraviolet.
Inflammation is the second major signal. When skin is injured or irritated, the cells release prostaglandins, leukotrienes, interleukin one, endothelin one, histamine and stem cell factor, and every one of these pushes melanocytes to make more pigment and to extend their dendrites. When the inflammation settles, the extra pigment stays in the keratinocytes and rides up and out on the normal clock. That is post-inflammatory hyperpigmentation, and it is the mechanism behind the darkened underarm, the dark mark after a pimple, the dark line where a bra rubs and the dark patch after a chemical peel that went too deep.
Hormones are the third. Melanocytes carry receptors for oestrogen and progesterone, and the skin of the face, the nipples, the genitals and the midline of the belly responds strongly to them. That is why pregnancy darkens the areolae and draws a dark line down the abdomen in a large share of pregnant women, why the genitals darken at puberty, and why melasma so often starts in pregnancy or on the contraceptive pill.
Signals from the deeper skin are the fourth. The fibroblasts of the dermis, the cells that make collagen, send their own messages to melanocytes, including stem cell factor and hepatocyte growth factor. In skin that has had years of sun, some fibroblasts age into a state called senescence and send these messages constantly. Research on melasma since about 2015 has shown that this conversation between damaged dermis and melanocyte is one reason melasma keeps coming back.
Insulin is the fifth, and it works differently. In acanthosis nigricans, high levels of insulin and of a related hormone, insulin-like growth factor one, drive the keratinocytes and fibroblasts to grow and fold. The skin thickens, builds up keratin and forms small ridges, and that thickening is most of what makes it look dark. The amount of melanin is only modestly raised. A brightening cream that blocks tyrosinase is therefore aimed at the smaller part of the problem, which is why creams barely touch acanthosis nigricans and why weight loss and insulin treatment can clear it.
Most extra pigment sits in the epidermis, inside keratinocytes that will be shed in a matter of weeks. That kind of pigment looks light to dark brown, it has sharp or soft edges depending on the cause, and it fades on the turnover clock once production slows. Under a dermatologist’s ultraviolet Wood’s lamp, epidermal pigment looks darker and better defined than in ordinary light.
Some pigment falls deeper. When the basement membrane is damaged, by strong inflammation, by certain rashes such as lichen planus, by an aggressive peel or laser, or by the slow damage of chronic sun, melanin escapes down into the dermis. There it is swallowed by scavenger cells called macrophages, which are then called melanophages, and they can sit in the dermis holding pigment for years. Dermal pigment looks blue-grey or slate-coloured, because the skin above scatters the shorter blue wavelengths back to the eye, a physical effect called the Tyndall effect. Under the Wood’s lamp, dermal pigment does not stand out.
Dermal pigment barely moves for three reasons. Topical ingredients that act on tyrosinase and transfer work at the melanocyte in the epidermis, and the pigment in the dermis is already finished and out of their reach. The turnover clock does not apply, because macrophages in the dermis are not shed at the surface. And the only tools that can break up dermal pigment are lasers that shatter it into fragments small enough for the body to clear, which carry their own risk of new inflammation and new pigment in darker skin. In real patients the two depths are often mixed. Melasma in particular usually has an epidermal and a dermal part, which is one reason it never clears completely with creams alone.
The Fitzpatrick scale was devised in 1975 by the Harvard dermatologist Thomas Fitzpatrick to estimate how much ultraviolet light patients could take during a light therapy called PUVA. It sorts skin by how it reacts to the first strong sun of the year. Type one always burns and never tans. Type two burns easily and tans a little. Type three sometimes burns and tans gradually. Type four rarely burns and tans well. Types five and six, added later, describe brown and dark brown to black skin that rarely or never burns.
The scale is useful in this market because almost every study of pigment reports its participants by Fitzpatrick type, and because the risk of PIH rises steadily from type three upward. The scale also has two limits that matter when you read a study or a brief. It was built on sunburn and tanning, and it predicts the response to inflammation only roughly, so two women of the same type can respond very differently to the same razor. And it was never meant as a scale of ethnicity, although brands and even some studies use it that way. Dermatologists who work mainly with skin of colour have proposed other scales, and the one that matters for marketing is the plain question a buyer can answer herself: whether a pimple, a scratch or a bug bite usually leaves a dark mark that lasts for months.
Three facts combine to produce the difference. The melanocytes in darker skin are more active at rest and respond to the same inflammatory signals with a larger burst of pigment, a behaviour dermatologists describe as labile. Their melanosomes are larger and degraded more slowly, so the extra pigment persists longer in the keratinocytes. And the contrast between the darkened patch and the surrounding skin is more visible, because the absolute amount of pigment added is larger. A 2010 review by Erin Davis and Valerie Callender found PIH more intense and more persistent in darker skin, and earlier work by Susan Taylor and colleagues reported acne-induced PIH in about sixty-five percent of the African American acne patients they studied, about fifty-three percent of the Hispanic patients and about forty-seven percent of the Asian patients.
The same activity cuts the other way. Darker skin can also lose pigment after injury, leaving pale patches, and a strong peel or laser can produce both dark and light patches in the same treated area. In lighter skin, the mark left after a pimple is more often red or pink than brown. That red mark, called post-inflammatory erythema, is made of small dilated blood vessels and does not respond to any brightener, a distinction the face market ignores and buyers rarely know.
Put the machine together and you can see every lever a product or a procedure can pull. The first lever is to remove the trigger, whether that is light, friction, a razor, an irritating product, insulin or a hormone. The second is to slow the enzyme tyrosinase. The third is to slow the hand-off of melanosomes to keratinocytes. The fourth is to speed the shedding of pigmented cells from the surface. The fifth is to calm the inflammatory and dermal signals that keep the melanocyte switched on, which is where antioxidants and tranexamic acid act. The sixth is to physically break up pigment, especially dermal pigment, with a laser or a light device.
Most brightening products pull only the second, third and fourth levers. Most of the durable results in the medical literature come from combining them with the first, and the first is the one the buyer usually has never been told about, because nobody sells it in a jar. Episodes three and four go through each condition in turn and name its trigger, which is the information the buyer is missing.
The face is where brightening was invented, where most of the research has been done and where the buyer learned her vocabulary. A woman who arrives at Doe with dark underarms has usually spent years reading about niacinamide percentages, tranexamic acid and alpha arbutin in the context of her cheeks, and she carries the face market’s promises, its clocks and its disappointments with her to every other part of her body. This episode covers the three main conditions of the face, melasma, acne marks and sun spots, plus the darker skin under the eyes, with the evidence for each and the place where buyers on each one get stuck.
A large survey gives the scale. The I’SPOT survey, run through the Ipsos panel with L’Oréal’s dermatological beauty division in late 2022 and early 2023, asked about forty-eight thousand adults in thirty-four countries to identify their own pigment problems from written descriptions and photographs. It was published in the Journal of Investigative Dermatology in November 2025 with Thierry Passeron as first author. Half of the respondents reported at least one pigment disorder. Sun spots were the most common at twenty-seven and a half percent, followed by darker underarms at seventeen point two percent, post-inflammatory hyperpigmentation at fourteen point eight percent, darkness around the eyes at fourteen point seven percent and melasma at ten point nine percent. These are self-reported figures, and a little over forty percent of the people reporting a disorder said a doctor had diagnosed it, so treat them as the size of the felt problem rather than a clinical count. Even so, the second-largest pigment complaint in the world, ahead of acne marks and melasma, is the underarm, and that should change how you think about Doe’s market.
Melasma is a patchy, symmetrical, brown to grey-brown darkening of the face. Melasma follows three common patterns on the face. The central pattern covers the forehead, the cheeks, the nose, the upper lip and the chin. The cheek pattern sits on the cheekbones. The jaw pattern runs along the jawline. Less often the same condition appears on the forearms. About nine in ten patients are women, and it usually starts between the twenties and forties. It is far more common in women with medium and darker skin, in Latin American, South Asian, East Asian, South-East Asian and Middle Eastern women in particular, and reviews put its prevalence at about one percent in general populations and anywhere from nine to fifty percent in high-risk groups, depending on how the group was chosen.
The triggers form a cluster rather than a single cause. Hormones start it in many women: melasma often appears during pregnancy, when it is called chloasma or the mask of pregnancy, or after starting the contraceptive pill. A family history is common, reported in roughly half of patients in several series. Ultraviolet light drives it and darkens it every summer. Visible light drives it in medium and darker skin, as the Detroit work by Mahmoud and colleagues showed in 2010. Heat is a suspected trigger, based on reports from women who work over stoves and ovens and on laboratory work, although the evidence is weaker than for light.
The biology explains why melasma is so stubborn. Biopsies show more melanin in the epidermis and more active melanocytes, without more of them. Some melanocytes hang down through a damaged basement membrane into the dermis, and pigment escapes with them. The dermis underneath shows sun damage, with clumped elastic fibres, more mast cells and more blood vessels, and the vessels release growth factors that stimulate melanocytes. Ageing fibroblasts in the dermis keep sending signals that switch melanocytes on. A group of researchers led by Passeron has argued that melasma is best understood as a disorder of sun-damaged skin in genetically predisposed women, with the pigment as the visible end of a process that starts in the dermis and the blood vessels. That framing explains why melasma relapses after every treatment, why it worsens every summer, and why lightening the epidermis alone never ends it.
The treatment evidence is the richest anywhere in the brightening literature. The foundation is protection from light, and since 2014 the evidence specifically favours protection from visible light. In a double-blind trial by Juan Pablo Castanedo-Cazares and colleagues in Mexico, sixty-eight patients with melasma all used four percent hydroquinone for eight weeks and were randomised to a sunscreen that blocked ultraviolet light alone or one that also blocked visible light with iron oxide pigments. The visible-light group improved fifteen percent more on the standard melasma score and twenty-eight percent more on colour measurement. A French trial by Boukari and colleagues tested the same idea for preventing relapse. Tinted sunscreen is now standard advice, and it is the single most important thing most melasma patients are not doing.
On top of light protection, the classic prescription is hydroquinone at four percent, or the triple combination first described by Albert Kligman and Willis in 1975, which paired hydroquinone with a retinoid and a steroid. A commercial version called Tri-Luma, with four percent hydroquinone, five hundredths of a percent tretinoin and one hundredth of a percent fluocinolone, was approved by the FDA in 2002 for courses of up to eight weeks. It works well on epidermal melasma and less well on the dermal part, and it irritates.
The newest systemic option is oral tranexamic acid, a drug used for decades to reduce heavy menstrual bleeding. It interferes with plasmin, an enzyme that links the blood vessel and inflammatory signals of melasma to the melanocyte. In a placebo-controlled trial by Del Rosario and colleagues published in 2018, forty-four women with moderate to severe melasma took two hundred and fifty milligrams twice a day or a placebo for three months. Thirty-nine completed the study. The melasma score fell by forty-nine percent on tranexamic acid and by eighteen percent on placebo, with few side effects. In the following three months on sunscreen alone, much of the benefit faded. Because it affects clotting, oral tranexamic acid is not given to women with a history of clots, and doctors take care with smokers and women on the pill. Topical tranexamic acid, which is in many face serums, has weaker and more variable trial results than the oral form.
Among cosmetic ingredients, thiamidol, developed by Beiersdorf and sold in Eucerin’s Anti-Pigment range, has the strongest comparative evidence. In a Brazilian trial by Lima and colleagues published in 2021, fifty women with facial melasma used either two tenths of a percent thiamidol or four percent hydroquinone for ninety days. The melasma score fell by about forty-three percent with thiamidol and about thirty-three percent with hydroquinone, a difference the authors judged not significant, and two of the thiamidol users developed an allergic rash. An earlier split-face study by Arrowitz and colleagues, funded by Beiersdorf, found thiamidol better than two percent hydroquinone. Cysteamine at five percent, kojic acid in combinations and azelaic acid at twenty percent each have small trials showing benefit.
Lasers are where melasma treatment most often goes wrong. In much of East Asia a technique called laser toning, which uses a low-energy Q-switched laser at one thousand and sixty-four nanometres across many sessions, became popular for melasma. It lightens the skin in the short term. A Korean retrospective study found that fourteen percent of patients treated with laser toning alone developed either white mottled spots or a rebound of darker pigment, and a 2022 systematic review found these complications more frequent in skin types four and five. All patients in at least one split-face trial had their melasma come back. In darker skin, any laser strong enough to injure the epidermis can cause new post-inflammatory pigment on top of the melasma it was meant to treat.
The valley in melasma has a particular shape. A woman treats it, often with a dermatologist’s cream or a series of peels or laser, sees it fade over two or three months, stops, and watches it return the next summer, sometimes darker. She tries a stronger product or a more aggressive procedure, and the inflammation from that treatment adds to the problem. After two or three cycles she concludes that nothing works and that she has been lied to. The counterintuitive truth that moves her is that melasma behaves like a chronic condition, closer to high blood pressure than to a stain, so the measure of success is control with a maintenance routine, and that the most important product in that routine is a tinted sunscreen used every day, including indoors near windows and in the car, because ordinary glass blocks most ultraviolet B light but lets visible light through. Gentle maintenance beats periodic aggression, and the woman who accepts that her melasma will need managing for years usually ends up with clearer skin than the woman who keeps trying to cure it.
The mark that stays after a pimple is the most common reason young women of colour see a dermatologist about pigment. Susan Taylor and colleagues, in a 2002 study of patients with skin of colour, found acne-induced PIH in sixty-five percent of the African American patients, fifty-three percent of the Hispanic patients and forty-seven percent of the Asian patients. For many of these women the marks bother them more than the acne itself, because a pimple lasts days and the mark lasts months.
The mechanism is ordinary post-inflammatory pigment. The inflamed pimple releases the signals described in episode two, the melanocytes respond, and the extra pigment stays in the keratinocytes. Untreated, epidermal acne marks fade over months, commonly six to twelve, and faster in lighter skin. Picking and squeezing deepen the injury and the mark, and occasionally push pigment into the dermis, where it lasts much longer.
The evidence on what speeds fading goes back to a 1993 paper in the New England Journal of Medicine by Bulengo-Ransby and colleagues. Fifty-four Black patients with dark marks on the face or arms used one tenth of a percent tretinoin or a vehicle cream for forty weeks. The marks on the tretinoin side became about forty percent lighter against about eighteen percent with the vehicle, and half the tretinoin users developed retinoid dermatitis, a red, peeling irritation, which eased over time. Azelaic acid, used for acne in creams of fifteen to twenty percent, has its own small trials in darker-skinned patients, and it has the advantage of treating the acne and the marks with a single ingredient. Thiamidol has a trial in acne marks, and niacinamide, vitamin C and alpha arbutin are used widely on the evidence of smaller studies.
There is a second kind of acne mark that the market almost never separates from the first. In lighter skin, the mark left after a pimple is often pink or red. That red mark is made of small dilated blood vessels and is called post-inflammatory erythema. It does not contain extra pigment, so brighteners do nothing for it, and it fades on its own or with a vascular laser. A buyer with red marks who buys a dark spot serum is buying the wrong product, and she will judge the whole category by her failure.
The valley for acne marks is that the woman treats the marks while the acne is still active. She buys brightening serums, exfoliating pads and sometimes harsh acne treatments together, the acne treatments and acids irritate, and every new pimple leaves a new mark, so the face never seems to clear. The counterintuitive aha is that the most effective brightening product for acne marks is whatever stops the acne, because each mark is fading on its own schedule while new ones are being added, and the net colour of the face depends far more on the rate of new marks than on the speed of fading. Gentle acne treatment plus daily sunscreen, with azelaic acid or a retinoid once the skin tolerates it, usually clears the marks faster than any serum used on top of active acne.
Sun spots, or solar lentigines, are flat, sharply edged brown spots on skin that has had many years of sun, most commonly on the face, the backs of the hands, the forearms, the shoulders and the upper chest. They are the most common pigment complaint in the I’SPOT survey and the dominant one in lighter skin from about forty onward. Under the microscope a lentigo shows the bottom of the epidermis pushed down into small finger-like ridges, with more melanocytes and more pigment at the base. That is a fixed local change, a small patch of skin that has been reprogrammed by sun to make more pigment, and it behaves differently from melasma and PIH.
Creams lighten sun spots slowly and partly, because the overproduction is built into the patch. Procedures remove them quickly. A Q-switched or picosecond laser, intense pulsed light or a quick freeze with liquid nitrogen can clear many lentigines in one or two sessions, with low risk in lighter skin. They come back over years with more sun, which is why sunscreen on the backs of the hands is part of the maintenance. Any brown spot that changes shape, colour or size, bleeds or itches belongs in front of a dermatologist, because a small share of spots sold as age spots are early melanomas or a slow-growing form called lentigo maligna.
The valley for sun spots is the dark spot corrector bought year after year, a jar of cream that lightens a spot by a shade over months and never removes it. The aha is that a sun spot behaves like a small fixed mark that a single procedure can remove, and that a cream’s real job on the hands is prevention through sunscreen. A woman of fifty-five who has spent a decade on hand creams usually learns this from a friend who walked out of a dermatologist’s office with clear hands after one appointment.
Darker skin under and around the eyes affected fourteen point seven percent of the I’SPOT respondents, and it is especially common in South Asian and Middle Eastern women. It has at least three components that mix in different proportions: real pigment in the skin, blood vessels and pooled blood showing through very thin skin, and the shadow cast by the shape of the eye socket and by puffiness. Brighteners help only the pigment part. Eye creams with caffeine or vitamin K address the vessels weakly. Filler in the tear trough changes the shadow. A buyer who sees no change after three months of a brightening eye cream may simply have a dark circle made mostly of vessels or shadow, which no brightener could ever reach.
Four habits of the face market follow the buyer to every other site. The first is the ingredient vocabulary, built around niacinamide at ten percent, alpha arbutin at two percent, tranexamic acid, vitamin C and azelaic acid, which she recognises and trusts. The second is the clock. Face serums promise visible change in four weeks, often supported by consumer perception panels in which most participants agree their skin looks brighter, and she expects the same of her underarms. The third is the before-and-after photograph, which taught her to expect a dramatic change and also taught her, after enough disappointments, to scrutinise every photograph for filters, lighting and matching nail polish. The fourth is the escalation habit, in which the answer to a slow result is a higher percentage or a stronger acid, a habit that is merely costly on the cheek and actively harmful in a shaved fold.
Episode four moves down the body, where the triggers change from light and hormones to friction, insulin and hair removal, and where the face’s habits do the most damage.
Below the chin the triggers change. Light still matters on the hands, the chest and the back of the neck, but most body pigment that women want to change sits on skin the sun rarely touches: the underarms, the inner thighs, the groin, the bikini line, the buttock crease, the knees and elbows and the nipples. On those sites the engines are friction, hair removal, insulin, hormones and the skin’s own reaction to whatever is put on it. This episode explains how body skin differs from facial skin, then goes through each of the body-specific conditions, and ends with a site-by-site map that you can carry into any brief.
Four physical facts make the folds a different environment from the cheek.
The first fact concerns the thickness and permeability of the skin. Skin in the folds and on the genitals is thinner and lets more of what is put on it through. The classic measurement comes from a 1967 study by Robert Feldmann and Howard Maibach, who applied radiolabelled hydrocortisone to different sites on volunteers and measured how much passed through. Taking the forearm as one, the underarm absorbed about three and a half times as much, the forehead about six times, the jaw about thirteen times and the scrotum about forty-two times. Vulvar skin is also known to be highly permeable. A concentration that is well tolerated on the forearm or the cheek can therefore deliver several times the dose in a fold, with several times the irritation.
The second fact is occlusion, meaning that the skin is covered. A fold is closed for most of the day, so it stays warm and humid, and anything applied there stays in contact with the skin under a natural wrap, which increases penetration further. Dermatologists use plastic film over a cream to make it stronger, and the armpit and groin do that by design.
The third fact is the acidity of the skin surface, measured as pH. Healthy skin has a slightly acidic surface, around four and a half to five on the forearm, which supports the barrier and the friendly bacteria. Folds run less acidic, often around six to six and a half in the armpit, because of sweat, moisture and bacterial activity, and a less acidic surface means a weaker barrier. Products that are very alkaline, such as baking soda deodorants, push it further in the wrong direction.
The fourth fact is mechanical, because the skin of a fold rubs against itself and against fabric all day. Arms swing against the chest wall, thighs rub against each other and against fabric, the buttocks press against a chair for hours, and knees and elbows take the weight of the body when it leans or kneels. Friction alone is enough to make keratinocytes release inflammatory signals, and repeated friction produces pigment in the same way repeated razors do.
Friction pigmentation has a name in the medical literature, friction melanosis, and its clearest description comes from Japan. In the 1980s and 1990s Japanese dermatologists described brown pigmentation over bony areas, the collarbones, the shoulder blades and the spine, in people who had scrubbed themselves every day for years with nylon bath towels and brushes. A second pattern was seen in young, thin women without any towel history, over the same bony points where clothing and bags rub. In some long-term scrubbers the skin also contained deposits of a protein called amyloid, a condition called friction amyloidosis, which is also reported in the Middle East and South Asia in people who scrub with loofahs and rough mitts. The treatment is to stop the scrubbing, and the pigment fades slowly over months.
This matters for brightening because the most common folk remedy for every dark patch on the body is to scrub it. Women in the Doe corpus describe exfoliating gloves, net sponges, washcloths and sugar scrubs in more than five hundred items, and the same habit runs through every forum about dark knees, elbows and thighs. Scrubbing removes dead skin and can brighten the surface for a day, and done daily it feeds the very process that made the patch dark.
Acanthosis nigricans deserves a fuller treatment here than in the deodorant course, because it is the condition most often confused with ordinary fold darkening and the one where the wrong product does the most harm to a buyer’s trust. It shows as dark, thickened, velvety skin, usually with soft, ill-defined edges, at the back and sides of the neck, in the armpits, in the groin, and sometimes on the elbows, knees and knuckles. Small skin tags often grow in the same areas. The texture is the key sign. Ordinary post-inflammatory darkening is flat and smooth, and acanthosis nigricans feels thick and slightly rough, like velvet or the skin of a peach.
Most acanthosis nigricans is caused by high insulin. When the body becomes resistant to insulin, the pancreas makes more of it, and at high levels insulin acts on receptors for insulin-like growth factor one on keratinocytes and fibroblasts, which drives them to grow. The skin thickens, folds into small ridges and builds up keratin, and that thickening is most of what makes it look dark. It is common with obesity, polycystic ovary syndrome and type two diabetes, and in American young people it is found far more often in Native American, African American and Hispanic children than in white children. In one adult obesity clinic it was found in seventy-four percent of patients, and in cohorts of women with polycystic ovary syndrome it appears in roughly half. Several drugs can cause it, including systemic steroids, high-dose niacin, some contraceptive pills, insulin injections at the injection site and some HIV medicines. A small share of cases have a different and serious cause: acanthosis nigricans that appears suddenly in an adult who is not overweight, spreads quickly, itches, or appears in the mouth or on the palms can be a sign of an internal cancer, most often of the stomach, and needs a doctor promptly.
Treatment follows the cause. Weight loss and anything that lowers insulin, such as diet change, exercise and medication prescribed by a doctor, often clears it over months, and the Doe corpus holds women who describe exactly that. Among creams, topical retinoids are the first choice in reviews, on the evidence of small studies, and keratolytic agents such as urea, glycolic acid and lactic acid soften the thickening. A 2025 systematic review of randomised trials of topical treatments covered tretinoin, urea, glycolic acid and others for the neck and underarm, and found the trials small. Brighteners that act only on tyrosinase or pigment transfer are aimed at the minor part of the problem. That is why the buyer with acanthosis nigricans so often reports that nothing worked, and why a page that hints it can treat her both fails her and invites a drug claim.
The skin of the labia, the vulva, the scrotum, the penis, the nipples and areolae, and the skin around the anus is darker than the surrounding skin in almost everyone, and more so in medium and darker skin. Melanocytes in these areas are highly responsive to sex hormones. The colour deepens at puberty, deepens again in pregnancy, and often deepens gradually with age. DermNet, the New Zealand dermatology reference, describes the dark line down the belly in pregnancy, the linea nigra, as present in more than ninety percent of pregnant women and often accompanied by darker nipples, areolae and genitals, more strongly in darker skin, though a pooled analysis of several studies in Cureus put the figure for the line nearer fifty-three percent. The same review lists the underarms, inner thighs and neck among the sites that commonly darken in pregnancy. Most of this colour fades partly after delivery, and some of it stays.
This hormone-driven pigment is a normal part of the body. It is a sex characteristic in the same sense that body hair is, and it needs no treatment. A whole category of intimate lightening creams, washes, peels and laser packages has been built against it, and episode seven covers the history, including an Indian intimate wash advertisement in 2012 that caused a national outcry. Within this area, two things are changeable and genuinely post-inflammatory: the darkening along the bikini line where hair is shaved, waxed or plucked, often with ingrown hairs, and the darkening from friction on the inner thigh where it meets the groin. Those two belong to the same family as the underarm.
Three infections of the folds are commonly mistaken for pigment. Erythrasma is a superficial infection by the bacterium Corynebacterium minutissimum that produces red-brown, finely scaly patches in the armpits, the groin and between the toes. It glows coral-red under a Wood’s lamp, because the bacteria make a pigment called a porphyrin, and it clears with an antibiotic such as erythromycin or topical clindamycin. Tinea cruris, the fungal infection called jock itch, makes an itchy red patch in the groin and inner thigh with a raised, scaly edge that spreads outward, and it often leaves a brown patch behind after it is treated. Tinea versicolor, caused by a yeast called Malassezia, makes small patches that can be lighter or darker than the surrounding skin on the chest, back and shoulders, mostly in hot and humid weather, and clears with antifungal washes such as ketoconazole.
The practical test for a buyer is itch and edge. A darkened patch with a defined, active-looking border, scaling, itch or a smell belongs with a pharmacist or doctor, because no brightener will touch it. Many brightening routines sold on TikTok include antibacterial or antifungal washes without saying why, and some of their happy customers probably had erythrasma or a fungus.
Terra firma-forme dermatosis is a dirt-like brown or grey crust that appears on the neck, the ankles, the trunk and the folds even in people who wash normally, because ordinary soap and water do not lift it. It comes off completely when rubbed with seventy percent isopropyl alcohol, which is both the diagnostic test and the cure in a case series of ten patients and many later reports. A related build-up, sometimes called dermatosis neglecta, comes from areas that are washed gently or avoided because they are sore. Deodorant, powder and lotion residue can also collect in folds and look darker than the skin.
Build-up explains the most common proof that buyers offer for scrubs, exfoliating pads and toners: the cotton pad comes away grey or brown. Part of that grey is dead skin, dirt and residue, and part of it is pigment in shed surface cells. The pad proves that something came off. It does not prove that the patch is lighter afterwards, and in the underarm and thigh the act of rubbing to make the pad grey adds friction to the skin.
Several medicines darken skin in recognisable patterns. Minocycline, an antibiotic often given for acne, can cause blue-grey patches on the shins, in old acne scars and on sun-exposed skin. Hydroxychloroquine, used for lupus and rheumatoid arthritis, can darken the shins and the roof of the mouth. Amiodarone, a heart rhythm drug, can turn sun-exposed skin slate-grey. Several chemotherapy drugs cause their own patterns. A fixed drug eruption, a reaction to a medicine such as an anti-inflammatory painkiller, an antibiotic or a sulfa drug, produces a round patch that flares in exactly the same place every time the drug is taken and leaves a dark mark, often on the lips, the hands or the genitals. Contraceptive pills can start melasma, as episode three covered.
Some products darken skin directly. Bergamot oil contains a compound called bergapten, a furocoumarin that reacts with sunlight, and perfume sprayed on the neck or wrists before going into the sun can leave a streak or drip-shaped brown mark called berloque dermatitis. It became rare after the fragrance industry, through the standards body IFRA, restricted furocoumarins and moved to bergapten-free bergamot, labelled FCF. Doe’s product is scented with vanilla and bergamot. The underarm is rarely sun-exposed, so the practical risk on that site is low, but the client should confirm that the bergamot is furocoumarin-free, especially if the brand ever extends the scent into a body or neck product.
Long-term use of hydroquinone at high strength can cause exogenous ochronosis, a permanent blue-black darkening with small dark bumps, in the very areas the user was trying to lighten. It was common in South Africa before 1984, when unregulated creams contained six to eight percent hydroquinone, often combined with resorcinol and phenol, and some studies from that period reported it in a large share of long-term users. It is rare at the two to four percent strengths used under medical supervision. Illegal lightening creams containing mercury or strong steroids cause other damage, which episode seven covers.
The neck darkens mainly from acanthosis nigricans at the back and sides, from friction with collars and necklaces, and from build-up in a skin crease. In darker-skinned women with eczema, a rippled grey-brown pigment at the front of the neck, sometimes called dirty neck, is a sign of the eczema rather than of dirt. In lighter skin with years of sun, a red-brown mottling on the sides of the neck that spares the shaded area under the chin is poikiloderma of Civatte, and perfume can leave berloque streaks. The neck is the site where the medical cause is most common, and where texture is the most useful first test.
The underarm darkens from a constitutional baseline in medium and darker skin, from post-inflammatory pigment caused by repeated hair removal and irritating products, from the shadow of dark hair under pale skin, and less often from acanthosis nigricans, erythrasma or build-up. In the I’SPOT survey seventeen point two percent of adults worldwide reported it, which makes it the second most common self-reported pigment complaint after sun spots.
The inner thighs darken mainly from friction where they meet, worse in heat, in exercise and with tight clothing, from shaving the edges of the bikini line, from acanthosis nigricans in women with insulin resistance, and from fungal infection and erythrasma in the groin crease. Hidradenitis suppurativa, a chronic inflammatory disease of the hair follicles in the armpits and groin, leaves dark scars and tracts in some women, and several women in the Doe corpus describe hiding it.
The bikini line and intimate area combine normal hormonal pigment with post-inflammatory pigment from hair removal and ingrown hairs along the line, and occasionally fungal infection.
The buttocks darken from the marks left by folliculitis, the small inflamed bumps around hair follicles that most people call butt acne, from friction and pressure where they meet a chair, from keratosis pilaris, and from the naturally darker skin of the crease.
The knees and elbows darken from friction and pressure, from thick, dry skin that scatters light and looks grey, and sometimes from acanthosis nigricans. People who kneel often develop darker, thickened knees, and studies from Saudi Arabia and elsewhere describe darker, thickened patches on the knees, ankles and forehead of Muslims who pray several times a day, which dermatologists call prayer marks.
The nipples and areolae are darker for hormonal reasons and darken further in pregnancy, and the only changeable part is any irritation from hair removal around the areola.
The hands carry sun spots on the backs with age, which respond to procedures and sunscreen. In darker skin the skin over the knuckles is often darker, which is normal. A specific cause worth knowing is vitamin B12 deficiency, which can darken the knuckles and the creases of the palms and reverses with B12, and which is more common in people on vegetarian or vegan diets without supplements. A rare hormonal cause, Addison’s disease, darkens the palm creases, the gums and scars along with fatigue and weight loss, and needs a doctor.
Laid out this way, the body splits into three groups. The first group is the sites where the colour is mostly a reaction to repeated injury, which a product and a change of habit can improve: the underarm, the bikini line, the inner thigh, the buttocks, the knees and the elbows. The second group is the sites where the colour is mostly a medical signal, led by the neck when it feels velvety, and any fold where acanthosis nigricans, infection or a drug is the cause. The third group is the sites where the colour is a normal feature of the body: the genitals, the nipples and the perianal skin, and the constitutional baseline of the underarm and groin in darker skin. A responsible brightening brand sells to the first group, routes the second to a doctor, and leaves the third alone. Episode nine uses this split to decide where Doe’s format can and cannot follow the buyer.
Every brightening product on every shelf, from a three-dollar kojic soap to a hundred-dollar prestige serum, is a combination of a small number of molecules, and each molecule pulls one or two of the levers from episode two. Once you sort them by lever, the marketing falls away and you can compare any two products in a few seconds. This episode goes through the ingredients in five groups: the enzyme blockers, the transfer blockers, the turnover agents, the antioxidants and signal blockers, and the procedures. It ends with the question that matters most for Doe, which is why the same ingredient that behaves well on a cheek can darken a fold.
Hydroquinone is the old standard and the benchmark every other ingredient is measured against. It acts as a decoy for tyrosinase, competing with the enzyme’s normal fuel, and it is also directly toxic to active melanocytes, which is why it works faster and harder than anything else in the cosmetic range. Dermatologists use it at four percent, often for three or four months at a time with breaks in between. In the United States it was sold over the counter at up to two percent until the CARES Act of March 2020 reformed the rules for non-prescription drugs and left hydroquinone without a valid monograph. From the twenty-third of September 2020, over-the-counter hydroquinone products became unapproved new drugs, and in April 2022 the FDA sent warning letters to twelve companies still selling them, saying it had received reports of rashes, facial swelling and ochronosis. The European Union removed hydroquinone from cosmetics in 2001, and many African and Asian countries restrict it.
Hydroquinone’s problems are irritation, rebound and long-term damage. In an Egyptian underarm trial of one hundred and fifty-three women, published by Mohammed in 2022, four percent hydroquinone caused redness or irritation in eighty-two percent of users over twelve weeks. When it is stopped, pigment often returns, sometimes darker. Used for years at high strength, it can cause exogenous ochronosis, the permanent blue-black darkening described in episode four. It remains the most effective topical brightener for epidermal pigment on the face under a doctor’s supervision, and the worst candidate for daily self-directed use in a shaved fold.
Kojic acid is a by-product of the fungus used to ferment rice for sake and soy sauce, which is where the name comes from. It blocks tyrosinase by binding the copper at the enzyme’s working site. Against the human form of the enzyme it is weak, with a half-inhibition concentration of about five hundred micromoles per litre in Tobias Mann’s 2018 screen at Beiersdorf, roughly four hundred and fifty times weaker than thiamidol. In combination it adds to other treatments: in a split-face melasma trial by Lim published in 1999, forty Chinese women used a gel of glycolic acid and hydroquinone with or without two percent kojic acid for twelve weeks, and more than half the melasma cleared on sixty percent of the kojic sides against forty-seven and a half percent of the others. Kojic acid is unstable in formulas, turning brown with air and light, and it can sensitise skin, meaning that some users develop an allergy after repeated exposure. The European Union’s scientific committee on consumer safety judged it safe at up to one percent in face and hand products in a 2022 opinion. Most kojic products sold for the body are soaps, which wash off within a minute, a limitation that Doe’s third philosophy is built around.
Arbutin is a natural sugar-bound form of hydroquinone found in bearberry leaves, and alpha-arbutin is a synthetic version that blocks tyrosinase more strongly. Both release small amounts of hydroquinone in the formula and on the skin, which is why European regulators set limits. Regulation 2024/996 allows alpha-arbutin at up to two percent in face creams and half a percent in body lotions, and beta-arbutin at up to seven percent in face creams. The lower body limit is worth remembering, because it applies a principle that runs through this whole episode: the body has far more skin than the face, so a body product delivers a larger total dose, and regulators allow less of the same ingredient in it. The Ordinary’s Alpha Arbutin two percent serum, sold for the face, is widely used by buyers on their underarms and thighs.
Azelaic acid is a natural acid made by the yeast Malassezia. It blocks tyrosinase and appears to act more on overactive melanocytes than on normal ones, and it also treats acne and rosacea. In the United States it is a prescription drug at fifteen and twenty percent, sold as Finacea and Azelex, and cosmetic versions at about ten percent are sold over the counter, including The Ordinary’s suspension. A 1998 vehicle-controlled trial in darker-skinned patients found twenty percent azelaic acid cream effective for facial pigment, and a 2011 pilot by Leon Kircik in twenty patients with skin type four found the fifteen percent gel reduced both acne and its marks over sixteen weeks. Azelaic acid tingles on application and is considered safe in pregnancy, which makes it the dermatologist’s frequent choice for pregnant women with melasma.
Phenylethyl resorcinol is a synthetic molecule sold by the German supplier Symrise as SymWhite 377. In Mann’s screen its half-inhibition concentration against human tyrosinase was about one hundred and thirty-one micromoles per litre, about four times as strong as kojic acid and much weaker than thiamidol. It is unstable in light, so suppliers often wrap it in capsules, and the European safety committee has judged it safe in leave-on products at up to half a percent. There is no independent controlled trial of phenylethyl resorcinol alone on human pigment. Its cousins in the resorcinol family include four-butylresorcinol, also called rucinol, which is stronger still at about twenty-one micromoles per litre, and four-hexylresorcinol, which has a randomised trial in combination with niacinamide.
Thiamidol, chemically isobutylamido thiazolyl resorcinol, came out of a screen of fifty thousand compounds at Beiersdorf and is the most potent human tyrosinase blocker in cosmetic use, with a half-inhibition concentration of about one micromole per litre. Its effect is reversible, and it does not appear to harm melanocytes the way hydroquinone does. It has the deepest trial record of any cosmetic brightener, across more than a dozen studies on melasma, acne marks and sun spots, including the fifty-woman comparison with four percent hydroquinone described in episode three. Beiersdorf owns it, so you find it in Eucerin and Nivea products, including a Eucerin Anti-Pigment body cream that pairs it with lactic acid and is marketed for friction areas such as knees and elbows. Two of the twenty-five thiamidol users in the Brazilian melasma trial developed allergic contact dermatitis.
Licorice root extract, and its active compound glabridin, block tyrosinase and also calm inflammation. It is common in Asian formulas and in sensitive-skin brighteners, with small trials behind it. L’Oréal has added its own molecule, Melasyl, which it describes as capturing pigment precursors before they become melanin, in La Roche-Posay’s Mela B3 serum launched in 2024, with company-funded data so far.
Niacinamide, a form of vitamin B3, does not touch tyrosinase. Tomohiro Hakozaki and colleagues at Procter and Gamble showed in 2002 that it reduced the transfer of melanosomes from melanocytes to keratinocytes by thirty-five to sixty-eight percent in cell culture, and that five percent niacinamide lightened facial spots against a vehicle within four weeks on instrument measurement. In a Mexican split-face study of twenty-seven women with melasma, Navarrete-Solís and colleagues found four percent niacinamide achieved good to excellent improvement in about forty-four percent of sides against fifty-five percent for four percent hydroquinone over eight weeks, with fewer side effects. In the underarm trial described in the deodorant course, four percent niacinamide produced a good-to-excellent response in twenty-four percent of women at nine weeks against six percent on placebo. Like every transfer blocker, its effect reverses within weeks when use stops. Most of the clinical evidence sits at two to five percent; the ten and twenty percent serums popular since The Ordinary’s Niacinamide ten percent with zinc are a marketing development, and at high strengths some users get redness and flushing.
Soy contains two proteins, soybean trypsin inhibitor and the Bowman-Birk inhibitor, that block the PAR-2 receptor through which keratinocytes take up melanosomes. Johnson and Johnson built Aveeno’s Positively Radiant line on this mechanism and published a twelve-week trial showing improvement in mottled pigmentation. Fresh, unprocessed soy extract is needed for the effect, since heat destroys the proteins.
The alpha hydroxy acids loosen the bonds between dead cells at the surface so that they shed faster, which carries surface pigment away sooner. Glycolic acid, from sugar cane, is the smallest molecule in the group, so it penetrates fastest and works hardest, and it irritates most. Lactic acid, from milk or fermentation, is larger, gentler and also draws water into the skin, which is why lactic lotions such as AmLactin are used for rough knees, elbows and keratosis pilaris. Mandelic acid, from bitter almonds, is the largest of the common acids, penetrates slowly and evenly and has some antibacterial action. In an Indian trial by Dayal and colleagues in 2020, mandelic acid peels matched salicylic acid peels for acne with fewer side effects and no new dark marks in the mandelic group. The FDA’s guidance for cosmetics containing alpha hydroxy acids recommends a sunburn alert on the label, because the acids increase the skin’s sensitivity to the sun for about a week after use.
Glycolic acid became a deodorant in 2022 when TikTok users began applying The Ordinary’s seven percent glycolic acid toning solution to their armpits. The acid lowers the skin’s pH, which suppresses the bacteria that make odor, and dermatologists quoted at the time agreed it could reduce smell and might help pigment while warning about irritation, especially after shaving, and noting that sweat dilutes it. The deodorant course traced how that trend split the buyers: in the Doe corpus, glycolic acid is the most discussed single product, it often helps odor, and the most liked complaint in the whole corpus is a woman saying it made her underarms darker.
Salicylic acid, the main beta hydroxy acid, dissolves in oil and works inside pores and hair follicles, which makes it useful for body acne, folliculitis on the buttocks and ingrown hairs. Its direct effect on pigment is small, so it earns its place on the body by preventing the bumps that leave marks.
The retinoids, a family of vitamin A molecules that includes prescription tretinoin and adapalene and cosmetic retinol and retinal, speed turnover, spread pigment more evenly through the epidermis and help other ingredients penetrate. The 1993 tretinoin trial in Black patients with dark marks, described in episode three, is still the reference. Half of its users developed retinoid dermatitis, and in darker skin that irritation can itself leave marks, so dermatologists start low and build up slowly. Retinoids are the first-choice topical in reviews for acanthosis nigricans, and they are avoided in pregnancy.
Urea at ten to forty percent softens and thins thickened skin and is used for acanthosis nigricans, rough heels and the dry, grey skin of knees and elbows.
Vitamin C, as L-ascorbic acid at ten to twenty percent in a low-pH serum, interrupts the chemistry of pigment formation by reducing its intermediate molecules and mops up the free radicals that ultraviolet light creates. It is unstable and oxidises in the bottle, turning yellow and then brown. More stable derivatives, such as ascorbyl glucoside and the oil-soluble tetrahexyldecyl ascorbate, are gentler and have less evidence. GloMelanin’s ads, for example, sell an oil-soluble vitamin C body oil by arguing that ordinary vitamin C never reaches the layer where pigment is made. Vitamin C’s brightening evidence is real and modest, and its strongest case is as a partner to sunscreen.
Tranexamic acid blocks plasmin, a protein-cutting enzyme that links blood vessels, inflammation and the melanocyte. Taken by mouth it has the strongest evidence of any newer melasma treatment, as episode three described, with the clotting caution that comes with it. Applied to the skin its results are weaker and more variable, but it is gentle and pairs well with niacinamide, which is why it anchors serums such as Good Molecules’ Discoloration Correcting Serum, Topicals’ Faded serum, Naturium’s tranexamic acid serum and Medicube’s TXA Niacinamide serum, the last of which Medicube advertises for underarms, elbows, knees and inner thighs.
Cysteamine is a small sulphur-containing molecule that the body makes naturally. At five percent in a cream applied for fifteen minutes and then washed off, because it smells of sulphur, it lightens melasma against placebo in a fifty-patient trial and performed close to four percent hydroquinone in a 2025 meta-analysis, though some trials found hydroquinone stronger. In the United States it is sold under the brand name Cyspera. It is one of the few brightening treatments designed to be short-contact, and its trials show that a wash-off product can work when the ingredient is strong enough, which is a nuance to keep in mind when Doe argues that wash-off kojic soaps cannot.
Chemical peels apply a high concentration of acid for minutes under supervision. Glycolic peels from twenty to seventy percent, salicylic peels at twenty to thirty percent, trichloroacetic acid peels and combination peels such as Jessner’s solution remove surface layers in a single session. Depigmenting masks such as Cosmelan and Dermamelan, made by the Spanish company Mesoestetic, combine several blockers in a mask left on for hours, and Mesoestetic sells an intimate version. In darker skin, superficial peels are generally safe and medium-depth peels carry a real risk of new pigment.
Lasers and light devices work by delivering energy that a target in the skin absorbs. For pigment, the target is melanin itself, which is the root of the problem in darker skin: the laser cannot tell the melanin of a dark spot from the melanin of the surrounding healthy epidermis, so in skin types four to six the whole surface absorbs more energy, heats more, and is more likely to blister and to respond with post-inflammatory pigment. Longer wavelengths, such as the one thousand and sixty-four nanometre Nd:YAG laser, pass through epidermal melanin more easily and are safer in darker skin. Intense pulsed light is generally avoided on dark skin. Laser toning for melasma, as episode three described, can leave white mottling or rebound darkening. Laser hair removal is a separate use that removes the reason to shave. In Toosi’s 2009 study of two thousand three hundred and fifty-nine alexandrite laser patients, the armpit was the most commonly treated site, complications occurred in two point two percent and temporary darkening in seven tenths of one percent, and darker skin is treated with the Nd:YAG wavelength.
Put together the physical facts from episode four and the ingredient facts above, and you can see why a product that is well tolerated on the face so often burns or darkens an underarm, a groin or an inner thigh.
The first difference is that the fold absorbs more of whatever is applied. Feldmann and Maibach’s measurements put the underarm at about three and a half times the forearm and genital skin far higher, and occlusion adds to that, so the same ten percent acid or two percent arbutin delivers a larger effective dose. That is the reason European rules cap alpha-arbutin at a quarter of its face level in body lotions.
The second difference is that the fold is usually already injured. A shaved underarm or bikini line has microscopic cuts and a thinned surface layer, so an acid that tingles on intact facial skin stings on shaved skin, and the sting is inflammation.
The third difference is that the fold rubs all day. Friction from the arm, the thigh or clothing works the product into the skin and adds its own inflammatory push.
The fourth difference is that the fold is less acidic and wetter than the face. Sweat dilutes products and changes their pH, and the higher surface pH of fold skin weakens the barrier against irritants and allergens.
The fifth difference is that the fold meets several other products every day. Fragrance, the leading cause of deodorant allergy, preservatives and propylene glycol all land on the same patch, and a sensitiser such as kojic acid has more chances to trigger an allergy under occlusion.
The consequence is the central fact for every body brightener: in a fold, irritation is the main cause of the colour, so a product that irritates is working against itself, and the threshold at which irritation begins is lower than on the face. The winning formula for fold skin is therefore a lower-strength, non-stinging blend used daily for months, rather than a high-strength product used intermittently.
On the face, instruments detect niacinamide’s effect at about four weeks, hydroquinone produces visible change in four to eight weeks with its best result at about twelve, tretinoin starts at about four weeks and keeps improving for months, azelaic acid needs eight to sixteen weeks, and oral tranexamic acid shows clear change by eight to twelve weeks. In the underarm, the placebo-controlled niacinamide trial measured its result at nine weeks, and a 2024 review of forty-six pigment studies in skin of colour found the earliest significant graded improvement at about twelve weeks. On the inner thighs, the bikini line and the buttocks there are no comparable timings, and the safest assumption is the fold’s: three months for a partial change.
Results drift back for three reasons. The trigger usually persists: the razor, the friction, the sun or the insulin is still there. The melanocyte keeps its settings, so as soon as the blocker is removed it resumes at the old rate, which is what the niacinamide reversal data show. And the turnover clock that carried the pigment away carries new pigment up just as quickly. The brightening products that keep results are the ones the buyer keeps using, which turns adherence, the dull matter of whether a product is still on the skin in month six, into the most important variable in the whole category.
Your question had a second half: is the literature for the underarm different from the literature for the face, and is it the same for the neck, the thighs and the intimate skin. The answer is that the mechanism literature is shared, because a melanocyte in the groin uses the same tyrosinase as a melanocyte on the cheek, and the clinical literature is wildly unequal. If the face has a library of trials, the underarm has a single shelf, and the inner thigh, the buttocks and the vulva have a few loose pages, most of them written by people selling the treatment. This episode walks through what exists for each site, with the size and length of every trial worth naming, and then draws the consequences for what a brand can claim.
The evidence for facial melasma alone is large enough to have its own systematic reviews. A Cochrane review of melasma treatments published in 2010 already pooled twenty randomised trials with more than two thousand participants, and the number of trials has grown several times over since then, driven by oral tranexamic acid, thiamidol, cysteamine and the newer lasers. Melasma trials share a scoring system, the Melasma Area and Severity Index, usually shortened to MASI, and its modified version, which lets one trial be compared with another. Acne marks have their own trials, with the 1993 tretinoin study in fifty-four Black patients over forty weeks as the reference, and a growing body of work on azelaic acid, thiamidol and niacinamide. Sun spots have both cream trials and a large procedure literature. Even the darkness around the eyes has its own trials.
The face evidence has limits that you should keep in mind. Many trials are small, often twenty to sixty people, and many are funded by the company that owns the ingredient, which is true of niacinamide at Procter and Gamble, thiamidol at Beiersdorf and phenylethyl resorcinol at Symrise. The participants skew toward particular populations: Latin American women dominate the melasma literature, and East and South Asian women dominate the laser literature. Still, a brand selling a face serum can point to a real body of controlled human evidence for most of the ingredients it uses, on the site where it uses them.
The underarm has about a dozen studies worth naming, and the deodorant course covered the most important ones. The paragraphs below gather them in one place, with numbers.
The anchor is a randomised, double-blind, placebo-controlled trial published in 2013 by Juan Pablo Castanedo-Cazares and colleagues in San Luis Potosí, Mexico. Twenty-four women aged nineteen to twenty-seven with medium to brown skin treated one underarm with four percent niacinamide and the other with either a mild prescription steroid, desonide, or a placebo, for nine weeks. A good to excellent response was seen in twenty-four percent on niacinamide, thirty percent on desonide and six percent on placebo, and the biopsies showed melanin and inflammatory cells falling together. That is the only placebo-controlled trial of a cosmetic brightener in the underarm, and it is small, short and from one population.
The largest underarm trial is an Egyptian study published by Mohammed in 2022, with one hundred and fifty-three women over twelve weeks, comparing an oil from the plant Cyperus rotundus with four percent hydroquinone and with placebo. Its most quoted finding is a side effect: hydroquinone caused redness or irritation in eighty-two percent of the women who used it.
Smaller studies of plant extracts, collected in a 2025 systematic review by Vahabi and colleagues, report instrument-measured changes. A perilla leaf serum lowered the melanin reading by about five percent at four weeks in thirty people, and a sweet orange peel extract lowered it from about three hundred and forty-nine to two hundred and fifty-three units at eight weeks in thirty-two people.
Exfoliating acids have weaker evidence. Two case reports describe eight percent glycolic acid cream combined with glycolic peels roughly halving underarm darkness scores by week eight. A split-underarm study of twenty women found that a forty percent acid peel improved colour by one grade in sixty-five percent, with burning and itching. One comparison found intense pulsed light did better than an alpha hydroxy acid cream. There is no underarm trial of mandelic acid, kojic acid alone or phenylethyl resorcinol alone.
Lasers have small uncontrolled series. A Q-switched one thousand and sixty-four nanometre laser produced good improvement in seventeen women after three or more sessions, and eighty-five to one hundred percent reduction in nine Filipino women after four sessions. Laser hair removal has large safety data, including the two thousand three hundred and fifty-nine patient alexandrite series, and no study has measured whether removing the hair fades the colour.
The mechanism studies complete the shelf. Andrew James and colleagues at Unilever took biopsies from twenty Filipino women in 2006 and linked underarm darkening to inflammation around the hair follicles and to plucking. Evans and colleagues, also at Unilever, showed in 2020 that a single session of shaving, plucking or waxing raised inflammatory signals in the underarm without producing pigment at forty-eight hours.
So the underarm has one small placebo-controlled trial of niacinamide, one larger trial whose main lesson concerns hydroquinone’s irritation, a few plant-extract studies with instrument readings, some acid and laser case series, and two industry biopsy studies. It is enough to support the mechanism of Doe’s story and a cautious clock of nine to twelve weeks. It is not enough to support any specific percentage of improvement for any product other than the one tested.
Most of the neck’s literature is about acanthosis nigricans. A 2025 systematic review of randomised trials of topical treatments for acanthosis nigricans on the neck and underarm covered tretinoin, urea, glycolic acid and other agents, with small trials, mostly of a few dozen patients and a few months each. A 2018 review in Clinical, Cosmetic and Investigational Dermatology called topical retinoids a first-line option on the evidence of small studies, found the trials of metformin mixed, and tied the best results to weight loss and correcting high insulin. The neck therefore has more controlled evidence than the thigh, and almost all of it concerns a medical condition that a cosmetic brand must stay clear of.
A search for randomised trials of inner thigh pigmentation returns blog posts, clinic pages and brand articles. There is no controlled trial that we could find of any cream for inner thigh darkening as its own condition. The thigh appears in studies of acanthosis nigricans and of laser hair removal, and clinicians write about friction, chafing and fungal infection, but the specific question a buyer asks, whether a product will lighten her inner thighs and how long it will take, has no published controlled answer. A dermatology practice answering patients on RealSelf warned that bleaching creams and lasers tend to work poorly in that area and can provoke more darkening, which is an opinion and fits the fold biology from episode five.
The evidence for the vulva, the perineum and the groin is a handful of small studies, nearly all without a control group. An abstract presented at the IMCAS Americas congress in 2023 described thirty-five patients with vulvar or perineal darkening treated with a new intimate chemical peel and reported reduced pigment, with no control group described. A small Brazilian study published in the journal Vittalle in 2024 tested a combination of mandelic acid and cysteamine and found that expert raters saw a reduction of about one grade on a groin and vulva colour scale while patients reported high satisfaction, and its authors called the lightening subtle. The Spanish company Mesoestetic cites a multicentre study of twenty-five women aged twenty-seven to fifty for its intimate depigmenting treatment, which is manufacturer material and unpublished as a peer-reviewed paper.
The safety literature for this area is more consistent than the efficacy literature. The skin is thin and highly permeable, it is partly mucous membrane, it is shaved and rubbed, and dermatologists quoted in the coverage of the 2012 Indian intimate wash controversy warned that the skin is easily irritated by lightening agents. Lasers in the area carry risks of burns, scarring and paradoxical darkening. Much of the colour being treated is physiological. Taken together, the intimate area is the site where the evidence for benefit is weakest and the risk of harm and of a drug or body-image claim is highest.
The buttocks have studies of folliculitis and keratosis pilaris and essentially none of pigment as such. The knees and elbows have occasional small studies, and brand claims such as Eucerin’s clinically tested label for its thiamidol body cream, without a published body-site trial that we could find. The nipples and areolae have no cosmetic lightening trials worth naming, and the subject appears mainly in the context of pregnancy physiology. The hands share the face’s sun spot literature, which is large and mostly about procedures.
Three consequences follow for anyone selling body brightening.
The first is that the body market borrows the face’s evidence. Nearly every body brand, Doe included, cites trials run on cheeks and in cell cultures to support a product sold for underarms and thighs. The borrowing is reasonable for mechanism, because the enzyme and the transfer step are the same everywhere. It is unreliable for dose, because a fold absorbs several times more and tolerates less, and unreliable for time, because the trigger on the body, whether a razor, friction or insulin, usually keeps running in a way that the trigger on a sun-protected face does not. When a body brand promises four-week results, it is borrowing a face clock and applying it to skin that is being re-injured every day.
The second is that most body claims rest on consumer perception panels. Doe’s own panel claim, as recorded in our brief, is a four-week self-assessment by thirty-three participants, in which ninety, ninety-four and ninety-one percent agreed with statements about brightness, dark spots and smoothness. A panel like that has no placebo group, uses the participants’ own judgment of a patch of skin they rarely look at closely, and runs a third of the length of the only controlled underarm trial. It can be used honestly only as a statement of what participants agreed with, phrased as “of thirty-three participants, a given number agreed that”, and never as a measured lightening rate. The FTC’s 2022 health products guidance expects claims about physical results to be backed by competent and reliable scientific evidence, and treats objective-sounding claims as needing objective measurement.
The third is an opportunity. Because the underarm has one small controlled trial and the inner thigh has none, a brand that runs a properly designed study on its own product, with a colour meter, a vehicle comparison, enough women of skin types three to six and a twelve-week endpoint, would own the only body-site evidence in its category. A study of forty to sixty women over twelve weeks is within reach of a small brand through a contract research organisation, and it would turn the weakest part of every competitor’s page into the strongest part of Doe’s.
The next episode turns from the science to the market itself: its size, its brands, its history in whitening and bleaching, and the rules on what can be said.
The brightening market is several markets that share a shelf: a mature face serum business, a fast-growing and fragmented body business, a small and controversial intimate business, a clinic business of peels and lasers, and an older global business in whitening and bleaching that the others try hard to distance themselves from. This episode sizes them, names the main brands and their positions, tells the history that shaped the vocabulary, describes the dangerous end of the market, and sets out the legal and platform rules that decide what Doe can say.
Published estimates of the global skin lightening market vary by a factor of four, because the research firms disagree about what to count. For 2024, Market Research Future put it at about four point six billion dollars, Fortune Business Insights at about nine point seven billion, IMARC at eleven point two billion, Straits Research and Bizwit at about eleven point six to eleven point eight billion, and Credence Research and Future Market Insights at about twenty billion. A reasonable working figure is eleven to twelve billion dollars a year, growing at five to eight percent, with Asia-Pacific the largest region. Treat all of these as industry estimates, sold as reports and built on different definitions of whether soaps, masks, body lotions and prescription creams belong inside.
In the United States, Circana’s data show where the growth is. Prestige beauty sales reached about thirty-six billion dollars in 2025, up four percent, and Circana’s analysts have described a skinification of everything, in which the ingredients and claims of face care spread to the scalp and the body. Body care has outpaced the wider skincare category in both prestige and mass channels since 2023, and buyers at retailers such as Credo have reported brightening products and liquid exfoliants as particular drivers. The size of the opportunity in scent-led body care is clearest at Sol de Janeiro, the Brazilian-inspired body brand owned by L’Occitane, whose sales reached about one point one three billion euros in the year to March 2025. Sol de Janeiro sells fragrance and pleasure on the body, and its success taught the whole category that body care can be a daily ritual people pay for. Doe’s vanilla and bergamot scent sits in that tradition.
The face market is mature and crowded, and almost every brand sells the same handful of ingredients. The Ordinary, the low-price brand from Deciem that Estée Lauder now fully owns, made single-ingredient serums at single-ingredient prices into a category, and its Niacinamide ten percent with zinc, Alpha Arbutin two percent and Glycolic Acid seven percent toning solution became the bathroom staples of a generation; that same toner became the TikTok deodorant. Good Molecules sells a Discoloration Correcting Serum built on tranexamic acid and niacinamide at a similarly low price. Topicals, founded by Olamide Olowe for chronic skin conditions in skin of colour, sells Faded, a serum with tranexamic acid, niacinamide and azelaic acid, at about thirty-eight dollars for fifty millilitres at Sephora, along with a Faded body bar. Naturium, which e.l.f. Beauty bought in 2023, sells tranexamic acid and niacinamide serums and body products. Paula’s Choice, owned by Unilever since 2021, sells exfoliating acids for face and body. Eucerin and La Roche-Posay sell the two proprietary molecules, thiamidol and Melasyl, through pharmacies.
The Korean brands play a different game. Medicube, from the Korean company APR, built a brightening line around its TXA Niacinamide serum and a set of kojic acid and turmeric body products, sells almost entirely through Amazon in the United States, and advertises at scale on Meta. Our study of its Meta ads, dated the fourteenth of October 2026 and based on ScrollStash data, counted five hundred and thirty-five unique Medicube ads over ninety days, about eighty percent video, with a median ad life of four days; eighty-four of the ads pointed to the TXA Niacinamide serum, with separate creatives for underarms, elbows, knees and inner thighs, and its kojic deodorant appeared only as a step inside routine videos. Those are counts of ads, unweighted by spend or sales.
The body market is younger and splits into six formats: soaps and washes, pads and scrubs, leave-on serums, oils and lotions, deodorants with actives, and supplements. Our competitor ad map, pulled through ScrollStash on the fifteenth of September 2026, gives the clearest picture of who is spending attention. Every figure below is a count of ads in ScrollStash’s tracked set, unweighted by spend or sales.
Lume, a deodorant brand that sells mandelic acid for odor control, had about one thousand and twenty-five ads, mostly on odor. Kallistia, which sells a supplement kit under the line “from the inside out”, had about nine hundred and seventeen, with the hook “Dark armpits, inner thighs, back breakouts. You can’t fix body skin issues with a face serum.” Earthly Derm, which sells a turmeric soap, had about five hundred and eighty-six, arguing that most dark underarm products cannot penetrate melanin-rich skin. GloMelanin, which sells a brightening body oil, soaps and dark spot creams to Black women under the line “Made for Melanin-Rich Skin”, had about five hundred and forty-seven, and its title ad was the longest-running in the set at two hundred and twenty-two days. Musely, a telehealth company that sells a prescription Private Cream for dark underarms and the intimate area, had about three hundred and seventy-six. Sugarbabycare, which sells kojic acid, turmeric and lemon pads for underarms, elbows and neck, had about two hundred and seventy. Truly Beauty, whose bundles include a brightening deodorant, had about two hundred and sixty.
Several smaller brands matter for their positioning. Bushbalm, a Canadian brand, built a business on the bikini line, selling a Nude Ingrown Hair Oil for ingrown hairs and dark spots on the bikini line and underarms, appearing on the Canadian television show Dragons’ Den with Arlene Dickinson in 2020, and moving into Ulta in the United States. Kojie San, from the Philippine company Beauty Elements Ventures, has sold kojic acid soap since about 2006 and describes itself, citing NielsenIQ, as the top-selling lightening soap in the Philippines; in 2024 it added glycolic, salicylic, niacinamide and vitamin C versions. In the deodorant aisle, Dove’s Even Tone line is the mass-market option, and Kosas, Nécessaire, Saltair, Naturium and Lume sell acid or brightening deodorants at prestige prices, alongside Medicube and Doe.
Three positions dominate the body market’s creative. The first is the ingredient position, where a face-famous active such as kojic acid, tranexamic acid or niacinamide is carried to the body. The second is the identity position, where the product is made for melanin-rich skin and the villain is products designed for other skin. The third is the inside-out position, where creams are dismissed and a supplement promises to fix the cause. Very few brands use the position that the science in this course most supports, which is that the colour is the skin’s reaction to a daily injury and that the product’s first job is to stop adding to it.
Intimate lightening is a small market with a large shadow. It includes washes, creams and serums sold for the bikini line, the inner thighs and the vulva, clinic peels and masks such as Mesoestetic’s Dermamelan Intimate, and laser packages sold by med spas. In India, brands such as Sanfe sell intimate lightening serums on Amazon, and one woman in r/IndianSkincareAddicts wrote that Sanfe’s serum “Surprisingly provided minor benefit by reducing hyperpigmentation by a little and also helped with moisturising the area pretty decently post shower.” The defining moment in this market came in 2012, when a television advertisement in India for Clean and Dry Intimate Wash showed a woman whose partner seemed uninterested until the product’s lightening effect revived his attention. The All India Democratic Women’s Association filed a complaint with the Advertising Standards Council of India, columnists and dermatologists criticised it, and the story ran in Time, the Huffington Post and Al Jazeera. The episode fixed intimate lightening in the public mind as a product sold through sexual shame, and it remains the reason serious brands handle the intimate area with great care or avoid it.
Skin lightening is old, and in several cultures it is tied to class and marriage. A Japanese proverb holds that white skin hides seven flaws, and the preference for pale skin in East Asia long predates European contact, linked to the idea that people who work indoors are wealthier than people who work in fields. In South Asia, Hindustan Unilever launched Fair and Lovely in 1975, and for decades its advertising showed women gaining jobs, confidence and husbands as their skin lightened. In the Philippines, whitening soaps, lotions and glutathione are mainstream. In much of sub-Saharan Africa and the Caribbean, skin bleaching with hydroquinone, steroids and mercury became widespread from the mid-twentieth century. A 2019 meta-analysis by Sagoe and colleagues in the International Journal of Dermatology pooled sixty-eight studies covering sixty-seven thousand six hundred and sixty-five people and estimated the lifetime prevalence of skin bleaching at about twenty-eight percent worldwide and about twenty-seven percent in Africa, with very wide variation between studies and higher figures in patient samples. A figure of seventy-seven percent of Nigerian women using lightening products is widely attributed to the World Health Organization; it appears in many articles, and we could not trace it to a primary survey, so treat it with caution.
The vocabulary shifted in two stages. From about 2019, Unilever moved Fair and Lovely’s communication away from fairness and toward glow, even tone, clarity and radiance. In June and July 2020, during the protests that followed the killing of George Floyd, it renamed the brand Glow and Lovely and its men’s line Glow and Handsome; Johnson and Johnson stopped selling its Neutrogena Fine Fairness and Clean and Clear Fairness lines; and L’Oréal announced it would drop the words white, whitening, fair, fairness, light and lightening from its skincare. The industry settled on brightening, even tone, glow, radiance and dark spots, words that describe the evenness and clarity of skin rather than its shade.
This history explains the two currents in Doe’s buyer corpus. American buyers say dark underarms, lighten and even out, and almost never say whiten. Filipino and South Asian buyers often say whitening without embarrassment, and the Doe corpus holds one hundred and twenty-eight items using that word, mostly from those lanes. On the other side stands the it is normal faction, whose embrace-it comments are the most liked in the entire corpus, at over one hundred and thirty-nine thousand likes for the top one, and who read any underarm brightening product as colourism in a new jar. The ethical line that holds up best is the distinction between evening a patch and lightening a person: Doe can honestly sell a product that helps a darkened, irritated patch move back toward the colour of the arm beside it, and it should never imply that the woman’s skin colour is the problem. The client’s own brand guidance already bans the words dirty, embarrassing, fix, whitening and bleach for this reason.
The bleaching market’s dangers are concrete. Mercury, once a common ingredient in lightening creams because it blocks melanin production, damages the kidneys and the nervous system. The Minamata Convention on Mercury required its parties to ban the manufacture, import and export of cosmetics containing more than one part per million of mercury by the end of 2020, and the Zero Mercury Working Group’s testing in 2019 found that around half of the lightening creams its partners bought online exceeded that limit. In 2019 a forty-seven-year-old woman in Sacramento, California, was left in a semi-comatose state by methylmercury in a Pond’s-labelled face cream that had been bought in Mexico and tampered with after sale, the first case of methylmercury in a skin cream reported in the United States; the California Department of Public Health said it had recorded more than sixty mercury poisonings from imported, unlabelled and homemade creams over the previous nine years.
Strong steroid creams, often clobetasol, are sold illegally as lighteners across Africa and South Asia because they lighten skin quickly. Used for months they thin the skin, cause stretch marks, acne and infections, and in heavy use suppress the body’s own hormone production. Long-term high-strength hydroquinone causes ochronosis, as episode four described. Several African countries, including Côte d’Ivoire in 2015, Ghana from 2016 and Rwanda in 2019, have banned or seized lightening products containing these ingredients. When a woman in Doe’s market says she is afraid of bleaching creams, or that a cream gave her stretch marks, this is what she is remembering, and Doe’s distance from that end of the market is a selling point.
In American law a product’s category is decided by its intended use, which the FDA reads from the label, the website and the advertising. A product intended to change the structure or function of the body, or to treat a disease, is a drug. A product intended to cleanse, beautify or alter the appearance is a cosmetic. Claims that a product lightens skin, bleaches it, inhibits melanin or treats hyperpigmentation are drug claims, and the FDA’s warning letters, including those of April 2022 to companies selling hydroquinone creams labelled as skin lighteners and earlier letters to brands describing products as skin lighteners that fade dark spots, show that it acts on that language. The cosmetic lane uses appearance language: the look of dark spots, a more even-looking tone, visibly brighter skin. Naming a disease such as acanthosis nigricans, melasma or hyperpigmentation as something the product treats moves it into the drug lane, which is one reason Doe’s principles forbid any claim about acanthosis nigricans.
The Modernization of Cosmetics Regulation Act of 2022, known as MoCRA, added requirements for facility registration, product listing, adverse event reporting and safety substantiation for cosmetics, which matters for a brand selling a kojic acid product on shaved skin. The Federal Trade Commission governs advertising truth. Its 2022 health products compliance guidance expects claims about physical results to be backed by competent and reliable scientific evidence, and consumer perception results to be presented as what participants said rather than as measured outcomes.
Meta’s advertising standards contain two rules that shape every brightening ad. The personal attributes rule forbids ads that assert or imply that the viewer has a particular trait, including a health condition, so a line that speaks directly to the viewer’s dark underarms as a fact about her is at risk, while a line in the first person or about a third party is safer. The health and appearance rule forbids ads that imply or try to create negative self-perception in order to sell a health or appearance product, and Meta’s own published example of a non-compliant ad is a before-and-after weight loss photograph. Several third-party guides published in 2026 describe a revision in July 2026 that allows cosmetic before-and-after images for audiences over eighteen; we could not confirm that revision on Meta’s own pages, so treat before-and-after imagery as high risk and check the live policy before any launch. Doe’s brief already limits before-and-after images to real, dated photographs taken in the same light, which also protects the brand from the audit that buyers run on every photograph, comparing nails, rings and tops across the two frames.
The next episode moves from the companies to the buyers, site by site: who they are, what they try, where they stall and what has burned them.
The brightening buyer is usually one woman with several sites, and the order in which she worries about them follows her age, her skin and her body. The deodorant course described the Doe buyer at length. This episode widens the lens to the woman who also worries about her neck, her thighs, her bikini line, her knees and her face, and asks what she buys first, where she stalls on each site and what has burned her. Every quoted line below is a buyer quote, taken word for word with its spelling, from the Doe research corpus of Reddit, TikTok and YouTube comments unless another source is named. Counts are items mentioning a theme in that corpus, which rank themes and do not measure the population.
The most important single finding for this course comes from Doe’s market map. Of the roughly ten thousand customer-voice items mined for the underarm, eight hundred and six mention a second body area, and the objection we labelled what about my thighs ranks in the top three objections on three of Doe’s five doors. Search behaviour says the same: the Google and Amazon suggest strings mined in September 2026 include ninety-three Google strings and forty-nine Amazon strings that pair dark armpits with the inner thighs, the neck, the elbows or the bikini area. The most liked comment in the TikTok corpus that names more than one site has twenty-eight thousand one hundred and sixty-five likes, and its writer listed three sites in one breath: “my neck ,inner thighs and armpit ls 😭😭😭😭depressing”
A post in r/30PlusSkinCare from 2025 shows the full shape of the multi-site buyer, a woman asking for “recommendations for products (or even routines) that actually work to lighten dark knees, elbows, underarms, and intimate areas, specifically for South Asian skin tones — think medium to deep brown.” Another, in r/IndianSkincareAddicts, described a twenty-one-year-old with “dark underarms, strech marks around my arms and hips, dark neck knees and inner thighs.” For this woman the face is one site among several, and the body sites are a single private problem with several locations.
The face buyer is the widest group and the best served. Acne-mark buyers skew young, from the late teens to the early thirties, and in darker skin the marks often bother them more than the acne. Melasma buyers skew older, usually from the late twenties to the fifties, with a heavy weighting toward Latin American, South Asian and East Asian women and toward women who are pregnant, recently postpartum or on the pill. Sun spot buyers are mostly lighter-skinned women over forty.
The face buyer’s sequence runs from a drugstore serum, to a named active such as niacinamide, vitamin C, alpha arbutin or tranexamic acid, to exfoliating acids, to a dermatologist’s hydroquinone or tretinoin, and for some to peels or laser. One Reddit poster in r/SkincareAddicts listed her acne-mark attempts this way: “For my face I’ve tried everything for the acne marks; the inkey list tranexamic acid serum, whitening creams, I apply sunscreen every day.” Another, whose post in r/SkincareAddiction drew one hundred and fifty upvotes, wrote, “I’ve tried many products, prescription hydroquinone, and even some laser treatments.” A poster in r/IndianSkincareAddicts reported the result that the literature predicts for hydroquinone with tretinoin, saying that “alternating tretinoin and hydroquinone every night actually faded the pigmentation noticeably.”
Where the face buyer stalls depends on her condition. The acne-mark buyer stalls by treating marks while new pimples keep arriving. The melasma buyer stalls at the relapse, usually in the first summer after treatment. The sun spot buyer stalls in years of creams that move a spot by a shade. What burns the face buyer most often is the strong treatment used without supervision: retinoid irritation, a peel that went too deep, laser that left rebound darkening.
The underarm buyer is the subject of the deodorant course, so a short recap will do. In Doe’s corpus her median stated age is twenty-two, while the paid buyer on Meta runs from twenty-five to fifty-four and buys best at thirty-five to forty-four. She is disproportionately Black, South Asian, Filipina, Latina or East Asian, with a separate lane of pale women with dark hair. Her sequence runs from kitchen remedies, to a change of hair removal, to acids and serums, to brightening deodorants, to bleaching creams, dermatologists and lasers. Her stall is the escalation loop, in which a stronger product irritates and darkens the skin, and her burns are glycolic acid, baking soda deodorants and hydroquinone. The comment that sums up the burn, with three thousand seven hundred and seventy-seven likes on TikTok, reads “i know most people swear by glycolic acid but all it did was make my underarms darker idk what i did wrong”. One poster in r/IndianSkincareAddicts described a self-prescribed combination cream containing hydroquinone, tretinoin and a steroid on her underarms, and the rebound when she stopped: “then I stopped for like 2-3 days and the hyperpigmentation came back worse than before ..”
The neck buyer lives in the medical lane more than any other, and she usually knows it. In the Doe corpus, the most upvoted posts about the neck sit in r/PCOS, r/PlusSize and r/AsianBeauty, and the neck is usually named together with the underarms. Her emotional state mixes shame about how the neck looks with fear about what it means. One poster in r/AsianBeauty wrote, “No matter how hot it is, I always keep my long hair down because my neck literally looks dirty.” A poster in r/PlusSize remembered being singled out as a child: “5th grade is when my mom got a letter from the school nurse saying that they thought the dark skin on my neck was acanthosis nigricans and to have me tested for diabetes.” A poster in r/PCOS described a mother whose only comments on her condition were about appearance: “Why do you smell?” “Why are your underarms or neck dark?”
Her sequence often starts with scrubbing, on the belief that the neck is dirty, moves to brightening creams and soaps, and then splits. Some women go to a doctor, hear the words insulin resistance and change their diet; others keep buying creams. Her stall is that nothing she puts on the skin works, because the colour is mostly thickening driven by insulin. The post with the most upvotes in the neck set, three hundred and seventy-seven in r/PCOS, states the stall exactly: “trying to become beautiful lost 30 kgs but the neck and armpits darkness won’t go away …what should I do”. The way out shows in other posts. One poster in r/PCOS wrote, “my period came back, dark neck and armpits which are signs of pre diabetes/ insulin resistance reversed.” A TikTok commenter with forty-eight likes wrote, “i have the same problem but when i lower my sugar the darkness fades some.”
The inner thigh buyer is the underarm buyer’s closest neighbour, and she often is the underarm buyer. The question she asks most, under nearly every underarm video in the corpus, is whether the same thing works on her thighs. The direct form, “Does it work for inner thighs 😔”, drew two thousand five hundred and fifty-four likes on TikTok, and a second commenter wrote “Need such magic for my inner thighs 😭” with four thousand nine hundred and sixty likes.
She comes in two main types. The first is the woman with heavier thighs, often in r/PlusSize or r/PCOS, who rubs and chafes and may also have insulin resistance. One poster in r/PCOS with fifty-two upvotes wrote, “I’ve had dark inner thighs since puberty and I have a lot of rubbing/friction/moisture in the area which makes it irritated too, my thighs are chubby and I have warm olive skin (Indian skin).” Later in the same post she wrote, “I’ve tried hydroquinone and tretinoin creams from dermatologists, all different percentages but nothing seems to help reduce the discoloration.” The second type is any woman whose thighs touch when she walks, runs or wears a skirt in summer, regardless of weight, plus the woman who shaves or waxes the edge of her bikini line.
Her emotional state is more private than the underarm buyer’s, because the thighs show in swimwear, shorts and intimacy rather than in every photograph. One YouTube commenter wrote, “I’m 27 yrs old and I’m still not able to have sex because I’m so conscious about my dark underarms and inner thighs.” A woman in r/blackladies wrote simply, “My inner thighs are darker than the rest of my body and I am insecure about it.” Her remedies are the underarm’s remedies moved down, along with petroleum jelly as a barrier: a TikTok reply with seven thousand three hundred and eight likes told a commenter to “use Vaseline my dear, you will be amazed by the results. It helps with dark inner thighs too”. Her stall is that every product meets a skin that is rubbed raw again the next day, and the evidence base gives her no clock at all.
This buyer is younger on average, from the late teens to the mid-thirties, and her concern often starts with hair removal. A poster in r/blackladies described the usual history: “Since I was probably 13 (now 24) I would always shave my bikini area but was extremely prone to ingrown hairs, dark marks, razor bumps, and my hair would start growing back like 4 days later.” In the same post she reported that “the laser has already helped with my dark underarms and bikini area”. Another poster, in r/SkincareAddiction, wrote, “I have hyperpigmentation spots on my bikini area and armpist how can i get rid of this its making me feel ugly :(”.
The intimate buyer’s emotional state is the most loaded of any site, because the question underneath is whether a partner will find her body acceptable. A poster in r/PCOS listed her “black bikini area, black private area, dark inner thighs, dark armpits and neck” and wrote that she had started “to worry if I’d ever be able to love myself enough to let someone love and see me too”. A poster in r/Hidradenitis wrote, “Im embarrassed to get diagnosed because my private area is very dark compared to my actual skin tone and Im scared of the judgement i will receive.” Her sequence runs from scrubs and lemon, to intimate washes and lightening serums, to bleaching creams and sometimes clinic peels or laser. What burns her is the strength of products made for other skin applied to the most sensitive skin on the body.
The counter-voice is strongest on this site. A commenter in r/SkincareAddiction wrote, “It’s completely normal to have slightly darker skin in your pits (along with your thighs, genitals, elbows, etc) I’m fairly pale too, and my underarms are pinker/duskier than the rest of me.” A TikTok commenter with six hundred and eighty-eight likes wrote, “dark armpits and inner thighs are normal. don’t be insecure about them .”
The buttocks buyer is usually treating the marks of folliculitis and body acne, often without knowing that the bumps and the marks are linked. A poster in r/IndianSkincareAddicts with thirty-eight upvotes listed her sites and her own diagnosis of each: “So I used it on areas where I feel I have the most prominent pigmentation: my butt, underarms and inner thighs (reasons: abscess infections that left dark spots, depilatory creams and alcohol deodorant throughout pre teen years, razor bumps respectively).” Another described using two Indian brands, “BeBodywise Pigmentation Repair and Kozivit on butt acne marks and underarms”. Her stall is the same as the face buyer’s: she fades the marks while the bumps keep coming.
The knees and elbows buyer is common among South Asian and Black women and often starts in childhood. A YouTube commenter with two hundred and forty-one likes wrote, “I notice a lot of woc suffer from darken underarms, elbows, and knees.” A TikTok commenter wrote, “Some girls wear sleeveless so confidently… meanwhile I’m still hiding my dark underarms and knees 🥺”. Her default tool is the scrub, and her most common success story involves gentler chemical exfoliation: a poster in r/IndianSkincareAddicts with seventy-one upvotes reported, “I’ve managed to lighten my underarms, knees and elbows,” after exfoliating with an acid product twice a week for about five weeks and then once a week. Her stall is scrubbing harder, which feeds friction pigmentation.
Across every site, three patterns repeat. The first is that the buyer frames the problem as a colour to be removed, when on most body sites it is a reaction to be stopped, whether the reaction is to a razor, a thigh, a scrub or insulin. The second is that she escalates in strength when progress is slow, and the folds punish escalation. The third is that her proof standard has hardened. The before-and-after objection appears on four hundred and sixty-nine items in the Doe corpus, and its most liked form is a TikTok comment with sixteen thousand two hundred and sixteen likes that reads “5 weeks same nails🤔”. She will believe a slow, partial, honestly photographed result more readily than a fast, complete one.
The final episode puts the valley and the aha on each of these sites and asks which of them Doe’s format can reach.
This last episode brings the course together in the form you will use most. For each body site it names the valley, meaning the place where most buyers stall and the belief that holds them there, and the aha, meaning the counterintuitive truth that moves them past it, with a proof the buyer can check for herself. Then it asks whether Doe’s deodorant format is the right answer to the underarm valley, and which neighbouring sites the same logic can and cannot reach, as a possible product line or a set of doorways.
The general valley has three floors. On the first floor, the buyer judges a product at three to six weeks, sees nothing, because the epidermis needs several turnover cycles before a change is visible, and concludes the product is too weak. On the second floor, she escalates to a stronger acid, a rougher scrub, a bleaching cream or a laser, the stronger product irritates the skin, and irritated skin in medium and darker tones makes more pigment, so the patch stays the same or darkens. On the third floor, anything that did work drifts back when she stops, because the melanocyte keeps its settings and the trigger is still running, and she concludes that nothing lasts. The belief holding all three floors together is that the colour is a deposit to be removed, like a stain, and that a stronger remover should work faster.
The general aha replaces the stain with a process. The colour is the slow output of pigment cells that are still being pushed by something, so the first job is to find and stop the push, the second is to slow the cells gently enough that the product never becomes a push of its own, and the third is to keep going for about three months and then keep a maintenance step. The proof she can check is her own history, because on almost every body site the darkest spot sits exactly where the push lands hardest: the crease where the razor drags, the point where the thighs meet, the back of the neck where insulin thickens the skin, the elbow she leans on.
For melasma, the valley is the relapse cycle. She clears it with a cream, peels or laser, stops, and watches it return the next summer, sometimes darker, and the belief holding her there is that melasma is a stain that a strong enough treatment can remove for good. The aha is that melasma behaves like a chronic condition of sun-damaged skin, driven partly by visible light that ordinary sunscreens and window glass let through, so the most important product is a tinted iron-oxide sunscreen worn every day, and gentle maintenance beats periodic aggression. The proof she can check is the calendar of her own relapses, which almost always follow summers, holidays and stopped routines.
For acne marks, the valley is fading marks while new pimples keep arriving, often with irritating acne products that leave marks of their own. The belief is that the marks are a separate problem needing a separate serum. The aha is that the best brightener for acne marks is whatever stops the acne, because the net colour of the face depends more on the rate of new marks than on the speed of fading, and that a red mark is made of blood vessels and needs no brightener at all. The proof is a month in which she counts new pimples and marks, then a month with the acne controlled.
For sun spots, the valley is years of dark spot creams that lighten a spot by a shade. The aha is that a sun spot is a fixed patch of reprogrammed skin that a single procedure can remove, with sunscreen to stop new ones. The proof is the friend who walked out of one appointment with clear hands.
The valley on the neck is scrubbing and brightening a patch that does not respond, because the buyer believes the neck is dirty or that she has ordinary pigment. The aha is that a dark neck that feels velvety and thick is usually skin thickened by high insulin, with only a little extra melanin, so the products aimed at melanin are aimed at the minor part of the problem, and the treatment that works is the one that lowers insulin. The proof she can check is texture: running a finger from the dark patch to the normal skin and feeling the change from smooth to velvet, then asking a doctor for a blood sugar test such as HbA1c. For the smaller group with smooth neck darkening, the aha is to look for friction from collars and necklaces, perfume sprayed on the neck before going into the sun, or a crust that comes off with an alcohol swab.
The underarm valley is the escalation trap described in the deodorant course: kitchen remedies, a change of hair removal, acids and serums, brightening deodorants, bleaching creams and lasers, with the silent weeks and the burns in between, and two exits labelled it is normal and it is medical. The belief holding it is that stronger is better, and that if a product does not sting it is not working. The aha has three parts: the colour is the skin’s response to being irritated again and again in a thin, folded, shaved patch, so gentle care beats strong care; the clock is nine to twelve weeks and the effect drifts back when the care stops, so the deciding variable is how many days in a row an active stays on the skin; and the one product she has never skipped since puberty is her deodorant. The proof she can check is one pit against the other, the crease against the inside of the upper arm, and a dated photo in the same light at the start and at week twelve.
The inner thigh valley is treating a rubbed patch with products made for a cheek while it is rubbed raw again every day. She scrubs, applies acids and bleaching creams, and sees no change or darker skin, and the belief holding her there is that the colour is pigment to be lightened, possibly because of her weight. The aha is that friction is the engine, so the first treatment is to stop the rub, with anti-chafe shorts under skirts, a slip-giving balm or stick on hot days and breathable fabric, and that thighs touch at every size, so the cause is mechanical rather than a judgment on her body. A second aha sits beside the first: a patch in the groin crease that itches, scales or has a spreading edge is probably a fungal or bacterial infection, which an antifungal or antibiotic clears and a brightener cannot. The proof she can check is the shape of the patch, which on a friction thigh matches the exact area where the thighs meet, and the difference in colour between the inner thigh and the outer thigh after a summer of stopping the rub.
The valley here combines two problems the buyer treats as one. Along the bikini line she has real post-inflammatory marks from shaving, waxing and ingrown hairs, and further in she has the normal, hormone-driven darker colour of the vulva and labia. She attacks both with scrubs, intimate washes and lightening creams, the thin skin burns, and the normal colour does not move. The aha is to separate the two: the line where the hair comes off is changeable, by reducing razor trauma, treating ingrowns with gentle exfoliation and considering laser hair removal, and the skin inside the line is normal pigment that deepened at puberty and in pregnancy and needs no treatment. The proof she can check is the boundary, because the irritated marks follow the line of the razor and the bumps of the ingrowns, while the hormonal colour follows the anatomy.
The buttocks valley is fading spots while the bumps that cause them keep coming. The belief is that the spots are pigment and the bumps are a separate nuisance. The aha is that most dark spots on the buttocks are the marks of folliculitis, inflamed hair follicles from sweat, friction and tight clothing, so the brightening treatment is an antibacterial or salicylic acid wash, a change out of sweaty clothes and fewer hours sitting in leggings, after which the marks fade on their own. The proof is that the marks sit exactly where the bumps were.
The knees and elbows valley is scrubbing harder. The belief is that the grey-brown colour is dead skin and dirt. The aha is that rubbing itself makes pigment, as the Japanese nylon towel studies showed, and that much of the greyness is thick, dry skin scattering light, so the treatment is to stop scrubbing, soften the skin with a lactic acid or urea lotion, and stop leaning on the elbows and kneeling on hard floors where possible. The proof is the colour of the knee after two weeks of lotion without scrubbing, compared with the shin below it.
For the nipples and areolae the valley is wanting a lighter colour that is normal, hormonal and deepened by pregnancy, and the aha is that there is no safe product that changes it meaningfully and no medical reason to try. For the hands, the valley is hand creams that do nothing for age spots, and the aha is sunscreen on the backs of the hands with a single procedure for existing spots, plus, in darker skin, the knowledge that darker knuckles are usually normal and occasionally a sign of low vitamin B12.
On the evidence in this course, the format is the right answer to two of the valley’s three floors, and it creates a new obligation on the third.
The format answers the clock. The underarm’s best trial needed nine weeks of daily application, the skin-of-colour review found the earliest graded change at about twelve weeks, and every result reverses when use stops. A leave-on product applied every morning to the exact patch, by a woman who has applied deodorant every morning since she was thirteen, is the most reliable delivery system for those conditions that any brand could design. A serum, a pad or a mask is a second routine, and second routines lapse. A kojic soap is rinsed off in under a minute.
The format answers the drift. Because the effect fades when use stops, a product she will keep buying for odor reasons keeps the brightening going, which turns the reversibility that undermines other products into a reason to subscribe.
The format creates a new obligation on gentleness. The advantage of daily contact cuts both ways, because a deodorant also delivers any irritant in it every day, under occlusion, often onto skin shaved minutes earlier. An irritant in a weekly mask is a weekly push; an irritant in a deodorant is a daily one, which is exactly the pattern that produces fold pigment. Doe’s formula therefore has to earn the gentle half of its story. The open questions from the brief remain the important ones: the kojic acid percentage, because kojic is a known sensitiser and the European ceiling is one percent; the phenylethyl resorcinol percentage, against a European safety ceiling of half a percent; whether mandelic acid is actually in the stick, since it is claimed in copy and missing from the ingredient list; the fragrance level, since fragrance is the leading cause of deodorant allergy; whether the bergamot is furocoumarin-free; and any repeat-insult patch test data. Magnesium hydroxide is a sensible odor active for this skin because it is less soluble and less alkaline at the surface than baking soda, though it still raises surface pH.
The format also leaves the trigger running. A deodorant does nothing about the razor, so the page that sells it should also teach the first lever: shave less often with a sharp blade and a lubricating gel, shave at night so the deodorant meets intact skin in the morning, avoid plucking, and consider laser hair removal with a wavelength suited to darker skin. Giving her the lever that nobody sells in a jar is the most credible thing a brand in this category can do.
The logic that makes the deodorant format work has four conditions: the colour is mostly post-inflammatory pigment, the trigger is a daily mechanical injury, the site already has a daily product that never gets skipped, and the skin can tolerate a gentle leave-on active. Run each neighbouring site through those four conditions and a product-line and doorway map falls out.
The inner thigh meets all four conditions more closely than any other site. The colour is mostly friction and shaving pigment, the trigger is daily, and anti-chafe sticks and balms, such as Megababe’s Thigh Rescue and Body Glide, are already a daily summer step for millions of women. A fragrance-free, slip-giving stick that stops the rub and carries niacinamide and a gentle exfoliant would be the closest possible extension of Doe’s logic, and the corpus demand for it is the loudest objection Doe already faces. Until such a product exists, the honest page answer to “does it work for inner thighs” is that the deodorant stays under the arm, with a short explanation of friction that the buyer will find useful anyway.
The bikini line meets three conditions. The colour along the line is post-inflammatory, the trigger is hair removal, and post-shave oils and serums are a growing daily or near-daily step, as Bushbalm’s business shows. The skin is thinner and closer to mucous membrane, so the product would need to be fragrance-free and lower in strength, and claims must stop at the line and never extend to the vulva or labia.
The knees and elbows meet two conditions. The colour is friction and dryness, and a body lotion is the natural daily vehicle, so the right product is a lactic acid or urea lotion with niacinamide. A stick format fits poorly, and the message has to lead with stopping the scrub.
The buttocks meet two conditions in a different form. The trigger is folliculitis, and the right vehicle is a salicylic or antibacterial body wash, which places the product closer to body acne than to brightening.
The neck fails the first condition for the buyers who need help most, because their colour is driven by insulin, and it fails the format test, because the neck belongs with the face and sunscreen. The honest doorway on the neck is educational: the velvet test and a route to a doctor, which earns trust without selling anything.
The intimate area and the nipples fail the first condition, because most of the colour is physiological, and they carry the highest regulatory and reputational risk in the category. Doe should leave them alone.
So the map, in order of fit, runs from the underarm, to the inner thigh as the natural second product, to the bikini line as a careful third, to knees and elbows as a lotion if the brand ever builds a body care range, with the neck held as a content doorway and the intimate area left out. Each of these sites also works as an ad doorway before any new product exists, because the woman who asks about her thighs under a Doe ad is telling you her second site, and an honest answer to her question is itself the kind of proof this market has stopped expecting.
The cheat sheet at the front of the book gathers the site map, the valley and aha for each site, the five numbers and the buyers’ phrases on one page for review before a brief or a meeting.
Send any of these as EPUBs and each can be digested into a follow-up episode. The ranking puts first the books that would most change how you read the brightening buyer and the claims you can make to her.
Internal paths are relative to /home/hq/Claude/offers/. Outside sources were gathered by web search on 2026-11-05; where only an abstract, a secondary summary or a press report was read, the entry says so. Evidence levels are given in brackets. Buyer quotes come from doe-deodorant/research/reddit/corpus.json, doe-deodorant/research/tiktok/comments.json and the YouTube harvest summarised in doe-deodorant/personas/MARKET-NOW.md, cited by subreddit or platform with their upvote or like counts as recorded there.